{"meta":{"page":1,"per_page":50,"max_per_page":100,"total":503,"total_is_capped":false,"direct_labels_cover":1,"predictions_cover":503,"direct_label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline (scores rank; they never assert a category)","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12","author_layer_release":"2026-06-26"},"query_hash":"c6c8d2e0904f","filters":{"venue":"Clinical Lymphoma Myeloma & Leukemia"}},"results":[{"id":"W2020431842","doi":"10.1016/j.clml.2012.08.003","title":"An Open-Label Single-Arm Pilot Phase II Study (PX-171-003-A0) of Low-Dose, Single-Agent Carfilzomib in Patients With Relapsed and Refractory Multiple Myeloma","year":2012,"lang":"en","type":"article","venue":"Clinical Lymphoma Myeloma & Leukemia","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":120,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Calgary; Beatrice Hunter Cancer Research Institute; Saint John Regional Hospital; Princess Margaret Cancer Centre; University of Toronto","funders":"Onyx Pharmaceuticals","keywords":"Carfilzomib; Medicine; Multiple myeloma; Bortezomib; Lenalidomide; Internal medicine; Thalidomide; Refractory (planetary science); Adverse effect; Regimen; Clinical endpoint; Phases of clinical research; Proteasome inhibitor; Anemia; Oncology; Surgery; Clinical trial; Gastroenterology","authors":[{"name":"Sundar Jagannath","is_ca":false},{"name":"Ravi Vij","is_ca":false},{"name":"A. Keith Stewart","is_ca":false},{"name":"Suzanne Trudel","is_ca":true},{"name":"Andrzej Jakubowiak","is_ca":false},{"name":"Tony Reiman","is_ca":true},{"name":"George Somlo","is_ca":false},{"name":"Nizar J. Bahlis","is_ca":true},{"name":"Sagar Lonial","is_ca":false},{"name":"Lori Kunkel","is_ca":false},{"name":"Alvin Wong","is_ca":false},{"name":"Robert Z. Orlowski","is_ca":false},{"name":"David S. Siegel","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.09475273562003522,"gpt":0.3770711989469108,"spread":0.2823184633268755,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001686316,0.0008714269,0.002014186,0.0004439703,0.0003557291,0.000113972,0.0007808536,0.0004214865,0.0001227134],"category_scores_gemma":[0.001824091,0.0006932717,0.0001391363,0.0007916698,0.000742705,0.001070715,0.0008524708,0.0006386352,0.00005502694],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001745443,"about_ca_system_score_gemma":0.0009343886,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000738723,"about_ca_topic_score_gemma":0.0003684796,"domain_scores_codex":[0.9923425,0.000961781,0.002284077,0.001487654,0.001377948,0.001546051],"domain_scores_gemma":[0.9938057,0.001098783,0.0007853577,0.001840135,0.0004899743,0.001980042],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.02838498,0.1665209,0.5206991,0.000106914,0.0004327616,0.0002772125,0.000610748,0.000001029471,0.002965114,0.00000919063,0.0001493968,0.2798426],"study_design_scores_gemma":[0.1478761,0.1186455,0.7302318,0.0003707744,0.0002401039,0.00002365951,0.0003265729,0.0002526472,0.001085648,0.00001059455,0.000413337,0.0005233036],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.993356,0.0003723918,0.00001102841,0.0000618213,0.0004000418,0.004728295,0.0001396401,0.0001247785,0.0008059687],"genre_scores_gemma":[0.9961042,0.00004726558,0.002124692,0.0002893831,0.000291751,0.0002403725,0.0004281646,0.0001907234,0.0002834359],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2793193,"threshold_uncertainty_score":0.9995518,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2808748371","doi":"10.1016/j.clml.2018.06.018","title":"Multiple Myeloma Treatment in Real-world Clinical Practice: Results of a Prospective, Multinational, Noninterventional Study","year":2018,"lang":"en","type":"article","venue":"Clinical Lymphoma Myeloma & Leukemia","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":89,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University Health Network","funders":"Janssen Pharmaceuticals; Takeda Oncology","keywords":"Medicine; Multinational corporation; Multiple myeloma; Clinical Practice; Oncology; Internal medicine; Family medicine; Law","authors":[{"name":"Mohamad Mohty","is_ca":false},{"name":"Evangelos Terpos","is_ca":false},{"name":"María‐Victoria Mateos","is_ca":false},{"name":"Michèle Cavo","is_ca":false},{"name":"Sandra Lejniece","is_ca":false},{"name":"Meral Beksaç","is_ca":false},{"name":"Mohamed Amine Bekadja","is_ca":false},{"name":"Wojciech Legieć","is_ca":false},{"name":"Meletios Α. Dimopoulos","is_ca":false},{"name":"Svetlana Stankovic","is_ca":false},{"name":"María Soledad Durán","is_ca":false},{"name":"Valerio De Stefano","is_ca":false},{"name":"Alessandro Corso","is_ca":false},{"name":"Yulia Kochkareva","is_ca":false},{"name":"Edward Laane","is_ca":false},{"name":"Christian Berthou","is_ca":false},{"name":"Hans Salwender","is_ca":false},{"name":"Zvenyslava Masliak","is_ca":false},{"name":"Valdas Pečeliūnas","is_ca":false},{"name":"Wolfgang Willenbacher","is_ca":false},{"name":"João Pedro Silva","is_ca":true},{"name":"Vernon Louw","is_ca":false},{"name":"Damir Nemet","is_ca":false},{"name":"Zita Borbényi","is_ca":false},{"name":"Uri Abadi","is_ca":false},{"name":"Robert Schou Pedersen","is_ca":false},{"name":"Peter Černelč","is_ca":false},{"name":"Anna Potamianou","is_ca":false},{"name":"Catherine Couturier","is_ca":false},{"name":"Caroline Feys","is_ca":false},{"name":"Florence Thoret-Bauchet","is_ca":false},{"name":"Mario Boccadoro","is_ca":false},{"name":"Rose‐Marie Hamladji","is_ca":false},{"name":"Hocine Ait Ali","is_ca":false},{"name":"Selma Hamdi","is_ca":false},{"name":"Hadj Touhami","is_ca":false},{"name":"Nourredine Sidi Mansour","is_ca":false},{"name":"Werner Linkesch","is_ca":false},{"name":"Robert S. Pedersen","is_ca":false},{"name":"Niels Abildgaard","is_ca":false},{"name":"Marju Hein","is_ca":false},{"name":"Jean Richard Eveillard","is_ca":false},{"name":"Abderrazak El Yamani","is_ca":false},{"name":"Philippe Moreau","is_ca":false},{"name":"Laurence Sanhès","is_ca":false},{"name":"G. Lepeu","is_ca":false},{"name":"Kamel Laribi","is_ca":false},{"name":"Éric Jourdan","is_ca":false},{"name":"Olivier Fitoussi","is_ca":false},{"name":"Olivier Allangba","is_ca":false},{"name":"Joël Fleury","is_ca":false},{"name":"Martine Escoffre","is_ca":false},{"name":"Riad Benramdane","is_ca":false},{"name":"Guillaume Cartron","is_ca":false},{"name":"Gérard Dine","is_ca":false},{"name":"Eric Legouffe","is_ca":false},{"name":"Hanns‐Detlev Harich","is_ca":false},{"name":"Thomas Illmer","is_ca":false},{"name":"Steffen Dörfel","is_ca":false},{"name":"Carla Hannig","is_ca":false},{"name":"Michael Koenigsmann","is_ca":false},{"name":"Gabriele Prange‐Krex","is_ca":false},{"name":"Ingo Tamm","is_ca":false},{"name":"W. Zeller","is_ca":false},{"name":"M. Maasberg","is_ca":false},{"name":"Rudolf Schlag","is_ca":false},{"name":"Martine Klausmann","is_ca":false},{"name":"Jens Uhlig","is_ca":false},{"name":"Burkhard Alkemper","is_ca":false},{"name":"Stefan Schütz","is_ca":false},{"name":"Hans-Werner Tessen","is_ca":false},{"name":"Benno Mohr","is_ca":false},{"name":"Peter Schmidt","is_ca":false},{"name":"Bernhard Heinrich","is_ca":false},{"name":"Holger Hebart","is_ca":false},{"name":"G. Seipelt","is_ca":false},{"name":"Thomas Zoeller","is_ca":false},{"name":"Frank Heits","is_ca":false},{"name":"Clemens Müller‐Naendrup","is_ca":false},{"name":"Richard Hansen","is_ca":false},{"name":"Roland Repp","is_ca":false},{"name":"Ludwig Fischer von Weikersthal","is_ca":false},{"name":"Rudolf Schmits","is_ca":false},{"name":"Jörg Heßling","is_ca":false},{"name":"B. Krammer-Steiner","is_ca":false},{"name":"Viktor Janzen","is_ca":false},{"name":"Michael Schauer","is_ca":false},{"name":"M Grüner","is_ca":false},{"name":"Jens Kisro","is_ca":false},{"name":"Claudio Denzlinger","is_ca":false},{"name":"Werner Freier","is_ca":false},{"name":"Christian Junghanß","is_ca":false},{"name":"Martin Görner","is_ca":false},{"name":"Katharina Laichinger","is_ca":false},{"name":"Helmut Ostermann","is_ca":false},{"name":"Heinz Dürk","is_ca":false},{"name":"Georg Heß","is_ca":false},{"name":"Gernot Reich","is_ca":false},{"name":"Panagiota Matsouka","is_ca":false},{"name":"Anastasia Pouli","is_ca":false},{"name":"Αchilles Anagnostopoulos","is_ca":false},{"name":"Tamás Masszi","is_ca":false},{"name":"J Ivánýi","is_ca":false},{"name":"Árpád Szomor","is_ca":false},{"name":"Arnon Nagler","is_ca":false},{"name":"Hila Magen","is_ca":false},{"name":"Irit Avivi","is_ca":false},{"name":"Miriam Quitt","is_ca":false},{"name":"Antonio Palumbo","is_ca":false},{"name":"Tommaso Zà","is_ca":false},{"name":"Daniele Vallisa","is_ca":false},{"name":"Roberto Foà","is_ca":false},{"name":"Alberto Bosi","is_ca":false},{"name":"Angelo Vacca","is_ca":false},{"name":"Francesco Lanza","is_ca":false},{"name":"Giulia Palazzo","is_ca":false},{"name":"Giuseppe Avvisati","is_ca":false},{"name":"Felicetto Ferrara","is_ca":false},{"name":"Ugo Consoli","is_ca":false},{"name":"Maria Cantonetti","is_ca":false},{"name":"Emanuele Angelucci","is_ca":false},{"name":"Catello Califano","is_ca":false},{"name":"Francesco Di Raimondo","is_ca":false},{"name":"Attilio Guarini","is_ca":false},{"name":"Maurizio Musso","is_ca":false},{"name":"Michele Pizzuti","is_ca":false},{"name":"Nicola Giuliani","is_ca":false},{"name":"Antonio Ardizzoia","is_ca":false},{"name":"Nicola Di Renzo","is_ca":false},{"name":"Gianluca Gaïdano","is_ca":false},{"name":"Alessandro Gozzetti","is_ca":false},{"name":"Vincenzo Pitini","is_ca":false},{"name":"Gabriella Farina","is_ca":false},{"name":"Riccardo Centurioni","is_ca":false},{"name":"Paolo de Fabritiis","is_ca":false},{"name":"Francesco Iuliano","is_ca":false},{"name":"Giorgio La Nasa","is_ca":false},{"name":"Giacinto La Verde","is_ca":false},{"name":"Fabrizio Pane","is_ca":false},{"name":"Umberto Recine","is_ca":false},{"name":"Maria La Targia","is_ca":false},{"name":"Giuseppe Mineo","is_ca":false},{"name":"Clotilde Cangialosi","is_ca":false},{"name":"Daniele Fagnani","is_ca":false},{"name":"Augusto B. Federici","is_ca":false},{"name":"Atelda Romano","is_ca":false},{"name":"Giorgina Specchia","is_ca":false},{"name":"Sergio Storti","is_ca":false},{"name":"Velia Bongarzoni","is_ca":false},{"name":"Andrea Bacigalupo","is_ca":false},{"name":"Marco De Gobbi","is_ca":false},{"name":"Giancarlo Latte","is_ca":false},{"name":"Donato Mannina","is_ca":false},{"name":"Silvana Capalbo","is_ca":false},{"name":"Mindaugas Jurgutis","is_ca":false},{"name":"Dariusz Woszczyk","is_ca":false},{"name":"Jadwiga Hołojda","is_ca":false},{"name":"Slawomir Gornik","is_ca":false},{"name":"Andrzej Pluta","is_ca":false},{"name":"Elżbieta Morawiec-Szymonik","is_ca":false},{"name":"Sławomira Kyrcz‐Krzemień","is_ca":false},{"name":"Wojciech Homenda","is_ca":false},{"name":"Sebastian Grosicki","is_ca":false},{"name":"K Sułek","is_ca":false},{"name":"Andrzej Lange","is_ca":false},{"name":"Janusz Kłoczko","is_ca":false},{"name":"Jolanta Starzak-Gwóźdź","is_ca":false},{"name":"Andrzej Hellmann","is_ca":false},{"name":"Mieczysław Komarnicki","is_ca":false},{"name":"Kazimierz Kuliczkowski","is_ca":false},{"name":"Carolina Viveiros","is_ca":false},{"name":"Cristina Gonçalves","is_ca":false},{"name":"Natalia Esefyeva","is_ca":false},{"name":"Julia Kochkareva","is_ca":false},{"name":"Kamil Kaplanov","is_ca":false},{"name":"Elena Volodicheva","is_ca":false},{"name":"Elena Laricheva","is_ca":false},{"name":"Valentina Dergacheva","is_ca":false},{"name":"Marina Chukavina","is_ca":false},{"name":"Natalia Volchenko","is_ca":false},{"name":"И. Н. Назарова","is_ca":false},{"name":"Л. В. Анчукова","is_ca":false},{"name":"Е. В. Ованесова","is_ca":false},{"name":"Т. А. Гриценко","is_ca":false},{"name":"Galina Salogub","is_ca":false},{"name":"Ludmila Magomedova","is_ca":false},{"name":"Irina Kuznetsova","is_ca":false},{"name":"Svetlana Osyunikhina","is_ca":false},{"name":"Olga V. Serdyuk","is_ca":false},{"name":"Elena Karyagina","is_ca":false},{"name":"Valentina Ivanova","is_ca":false},{"name":"S Cernelc","is_ca":false},{"name":"Corlia Coetzee","is_ca":false},{"name":"Karen Gunther","is_ca":false},{"name":"Dhayanithi Moodley","is_ca":false},{"name":"Soledad Durán","is_ca":false},{"name":"Asunción Echeveste Gutiérrez","is_ca":false},{"name":"Jaime Pérez de Oteyza","is_ca":false},{"name":"Francisco Capote","is_ca":false},{"name":"María Casanova","is_ca":false},{"name":"Eduardo Ríos","is_ca":false},{"name":"Jeronima Ibañez-Garcia","is_ca":false},{"name":"María José Herranz","is_ca":false},{"name":"Belén Hernández","is_ca":false},{"name":"Sara Sanchez Sanchez","is_ca":false},{"name":"Fernando Escalante","is_ca":false},{"name":"Fernando Carnicero","is_ca":false},{"name":"Mercedes Gironella","is_ca":false},{"name":"Rafael Martínez","is_ca":false},{"name":"A. López de la Guía","is_ca":false},{"name":"Luis Palomera","is_ca":false},{"name":"Rebeca Iglesias","is_ca":false},{"name":"F. Solano Ramos","is_ca":false},{"name":"Javier de la Serna","is_ca":false},{"name":"Pedro Garcia Sanchez","is_ca":false},{"name":"Juan Besalduch Vidal","is_ca":false},{"name":"Miguel Diaz Morfa","is_ca":false},{"name":"Turkey – Meral Beksac","is_ca":false},{"name":"Filiz Vural","is_ca":false},{"name":"Yıldız Aydın","is_ca":false},{"name":"Ali Ünal","is_ca":false},{"name":"Hakan Göker","is_ca":false},{"name":"Oktay Bilgir","is_ca":false},{"name":"Birol Güvenç","is_ca":false},{"name":"Mehmet Turgut","is_ca":false},{"name":"Gülsüm Özet","is_ca":false},{"name":"Rıdvan Ali","is_ca":false},{"name":"Maryna Kyselyova","is_ca":false},{"name":"Nataliia Glushko","is_ca":false},{"name":"Renata Vybyrana","is_ca":false},{"name":"Ігор Миколайович Скрипник","is_ca":false},{"name":"N. M. Tretyak","is_ca":false},{"name":"Tetiana Kharchevska","is_ca":false},{"name":"Iryna Dyagil","is_ca":false},{"name":"Tetiana Popovska","is_ca":false},{"name":"V N Shimanskiy","is_ca":false},{"name":"Tamila Lysa","is_ca":false},{"name":"Hanna Oliynyk","is_ca":false},{"name":"Kateryna Vilchevskaya","is_ca":false},{"name":"Iryna Kryachok","is_ca":false},{"name":"Yuriy Popovych","is_ca":false},{"name":"Natalia Romanyuk","is_ca":false},{"name":"Polina Kaplan","is_ca":false},{"name":"Grygoriy Rekhtman","is_ca":false},{"name":"Halyna Pylypenko","is_ca":false},{"name":"В. В. Козлов","is_ca":false},{"name":"Johannes Drach","is_ca":false},{"name":"Jean‐Luc Harousseau","is_ca":false},{"name":"Hermann Einsele","is_ca":false},{"name":"Hartmut Goldschmidt","is_ca":false},{"name":"Thierry Façon","is_ca":false},{"name":"Mauricette Michalet","is_ca":false},{"name":"Savchenko Vg","is_ca":false},{"name":"Javier de la Rubia","is_ca":false},{"name":"Gordon Cook","is_ca":false},{"name":"Ulf‐Henrik Mellqvist","is_ca":false},{"name":"H Ludwig","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.08839271982467811,"gpt":0.45732599415284,"spread":0.3689332743281619,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.004158187,0.0006212291,0.001779023,0.0006177092,0.0002177793,0.00005692473,0.0004360635,0.0004063049,0.000240148],"category_scores_gemma":[0.0156256,0.0005047767,0.000977092,0.001137689,0.00119855,0.0003727357,0.0003393516,0.0004878622,0.0005293978],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00267761,"about_ca_system_score_gemma":0.002778066,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003532015,"about_ca_topic_score_gemma":0.006376223,"domain_scores_codex":[0.9900174,0.001468505,0.004395748,0.001731472,0.00147799,0.0009089193],"domain_scores_gemma":[0.9883669,0.00666029,0.001164848,0.001438746,0.001567851,0.0008013361],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.02302954,0.01830981,0.696658,0.00003525006,0.001050703,0.001129212,0.0003170009,0.000001878432,0.00003819993,0.0001719986,0.0009519074,0.2583065],"study_design_scores_gemma":[0.07133564,0.01603306,0.9016356,0.0002942322,0.0003039577,0.00008362451,0.0004503085,0.002159386,0.0004118376,0.0001167451,0.006826967,0.0003486152],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9762788,0.0001017005,0.00002530158,0.0006319591,0.0006068428,0.003844759,0.0001896151,0.0001414941,0.01817948],"genre_scores_gemma":[0.9844839,0.0001841922,0.008227562,0.000180213,0.001245506,0.0004331403,0.0002702941,0.0000865293,0.004888666],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2579579,"threshold_uncertainty_score":0.9997404,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2016111806","doi":"10.1016/j.clml.2014.12.008","title":"Effects of Ruxolitinib Treatment on Metabolic and Nutritional Parameters in Patients With Myelofibrosis From COMFORT-I","year":2014,"lang":"en","type":"article","venue":"Clinical Lymphoma Myeloma & Leukemia","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":87,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"University of Texas MD Anderson Cancer Center; National Cancer Institute; National Institutes of Health; Incyte; Gilead Sciences; Sanofi; Genentech; Celgene; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Ruxolitinib; Myelofibrosis; Medicine; Placebo; Internal medicine; Clinical endpoint; Gastroenterology; Post-hoc analysis; Randomized controlled trial; Surgery; Bone marrow; Pathology","authors":[{"name":"Ruben A. Mesa","is_ca":false},{"name":"Srđan Verstovšek","is_ca":false},{"name":"Vikas Gupta","is_ca":true},{"name":"John Mascarenhas","is_ca":false},{"name":"Ehab Atallah","is_ca":false},{"name":"Timothy C. Burn","is_ca":false},{"name":"William Sun","is_ca":false},{"name":"Victor Sandor","is_ca":false},{"name":"Jason Gotlib","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01370294947349546,"gpt":0.2692774016353615,"spread":0.255574452161866,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001836766,0.0004213139,0.001332531,0.00015107,0.00006643289,0.00002205499,0.0000859772,0.0002326893,0.00002598706],"category_scores_gemma":[0.0003357088,0.0002885225,0.0002356991,0.0001813871,0.0003074607,0.00007278625,0.00004114707,0.0001221319,0.00002755888],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003899363,"about_ca_system_score_gemma":0.0002163021,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002731963,"about_ca_topic_score_gemma":0.00002976652,"domain_scores_codex":[0.9973273,0.000282521,0.0008609591,0.000714589,0.00044095,0.0003736553],"domain_scores_gemma":[0.9955308,0.003301759,0.0002732734,0.0004152026,0.0001041945,0.0003747437],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.002753765,0.00278225,0.7236431,0.00005648013,0.0003589183,0.00002930976,0.00005770749,0.000004469618,0.00002357277,0.001030421,0.00005518412,0.2692048],"study_design_scores_gemma":[0.03198386,0.007686015,0.9483048,0.0006278123,0.0004349133,0.000003482387,0.00001021059,0.0001033551,0.008983926,0.0003624578,0.001255277,0.0002439149],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9975336,0.0002663501,0.00001169562,0.0001673713,0.0001156622,0.001354812,0.0001042809,0.00003524352,0.0004109453],"genre_scores_gemma":[0.9952232,0.0003335978,0.002756009,0.0007856673,0.0001284873,0.0004182326,0.0002774306,0.00004221817,0.00003513688],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2689609,"threshold_uncertainty_score":0.9999567,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2083459234","doi":"10.3816/clml.2010.n.059","title":"Phase II Study of Obatoclax Mesylate (GX15-070), a Small-Molecule BCL-2 Family Antagonist, for Patients With Myelofibrosis","year":2010,"lang":"en","type":"article","venue":"Clinical Lymphoma Myeloma & Leukemia","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":87,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Ontario Institute for Cancer Research; Princess Margaret Cancer Centre","funders":"","keywords":"Myelofibrosis; Medicine; Internal medicine; Anemia; Adverse effect; Gastroenterology; Cyclophosphamide; Rash; Surgery; Chemotherapy; Bone marrow","authors":[{"name":"Sameer A. Parikh","is_ca":false},{"name":"Hagop M. Kantarjian","is_ca":false},{"name":"Aaron D. Schimmer","is_ca":true},{"name":"William Walsh","is_ca":false},{"name":"Ekatherine Asatiani","is_ca":false},{"name":"Khaled El‐Shami","is_ca":false},{"name":"Elliott F. Winton","is_ca":false},{"name":"Srđan Verstovšek","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02810113146998339,"gpt":0.3297646416348803,"spread":0.3016635101648969,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005947117,0.0007238982,0.001797212,0.0001864281,0.0004376525,0.0000596891,0.0003728965,0.0004573674,0.00008201716],"category_scores_gemma":[0.0006563284,0.0005257868,0.0005417772,0.0004388641,0.0004380795,0.0001387624,0.0002228399,0.0003936429,0.00004660479],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000357174,"about_ca_system_score_gemma":0.001229465,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001520219,"about_ca_topic_score_gemma":0.0001599115,"domain_scores_codex":[0.9951707,0.0001788756,0.001871563,0.001290387,0.00072577,0.0007627259],"domain_scores_gemma":[0.9954002,0.0009875308,0.000751933,0.001269994,0.0008824968,0.0007077731],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.01477071,0.04927507,0.503628,0.0001999428,0.00177833,0.0001934988,0.000640886,0.000002367996,0.00362709,0.0003618186,0.00201131,0.423511],"study_design_scores_gemma":[0.08139604,0.06599637,0.8374758,0.0002095247,0.001133796,0.00002332281,0.0002122343,0.0002283779,0.007169161,0.00005336029,0.005530482,0.0005715378],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9924192,0.00007870701,0.00005832024,0.0001973359,0.0005873116,0.005435687,0.000228145,0.0001347121,0.0008605268],"genre_scores_gemma":[0.9936135,0.00005646936,0.003121843,0.000642597,0.0003548597,0.001386824,0.0002952471,0.0001359933,0.0003926573],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4229394,"threshold_uncertainty_score":0.9997194,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2810788428","doi":"10.1016/j.clml.2018.06.016","title":"Safety Analysis of Four Randomized Controlled Studies of Ibrutinib in Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma or Mantle Cell Lymphoma","year":2018,"lang":"en","type":"article","venue":"Clinical Lymphoma Myeloma & Leukemia","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":81,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McMaster University; Juravinski Cancer Centre","funders":"Pharmacyclics","keywords":"Ibrutinib; Medicine; Mantle cell lymphoma; Chronic lymphocytic leukemia; Internal medicine; Adverse effect; Discontinuation; Oncology; Lymphoma; Leukemia","authors":[{"name":"Susan O’Brien","is_ca":false},{"name":"Peter Hillmen","is_ca":false},{"name":"Steven Coutré","is_ca":false},{"name":"Paul M. Barr","is_ca":false},{"name":"Graeme Fraser","is_ca":true},{"name":"Alessandra Tedeschi","is_ca":false},{"name":"Jan A. Burger","is_ca":false},{"name":"Marie‐Sarah Dilhuydy","is_ca":false},{"name":"Georg Heß","is_ca":false},{"name":"Carol Moreno","is_ca":false},{"name":"Paula Cramer","is_ca":false},{"name":"Emily Liu","is_ca":false},{"name":"Stephen Chang","is_ca":false},{"name":"Jessica Vermeulen","is_ca":false},{"name":"Lori Styles","is_ca":false},{"name":"Angela Howes","is_ca":false},{"name":"Danelle F. James","is_ca":false},{"name":"Kalpesh Patel","is_ca":false},{"name":"Thorsten Graef","is_ca":false},{"name":"Rudolph Valentino","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03911592668850494,"gpt":0.3368084978425915,"spread":0.2976925711540866,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch","metaepi_narrow","metaepi_broad","sts","research_integrity"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.008103445,0.001912187,0.01589773,0.002798805,0.0003482884,0.00008732928,0.001760187,0.001421829,0.0006390303],"category_scores_gemma":[0.0100577,0.001306243,0.003864979,0.006479516,0.007125065,0.0003972948,0.001053988,0.0003680578,0.0002191148],"about_ca_system_candidate":true,"about_ca_system_consensus":true,"about_ca_system_score_codex":0.1978107,"about_ca_system_score_gemma":0.14271,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00345181,"about_ca_topic_score_gemma":0.001427738,"domain_scores_codex":[0.9791838,0.002599278,0.009627544,0.002785563,0.003173529,0.002630299],"domain_scores_gemma":[0.9722911,0.01541881,0.004036098,0.003726349,0.003337994,0.001189666],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8570135,0.001734735,0.01713524,0.002067723,0.02479117,0.001000234,0.001024859,0.001445583,0.0001626378,0.000293128,0.0004908,0.09284034],"study_design_scores_gemma":[0.6987156,0.004202589,0.1893594,0.001541701,0.01104506,0.0001133739,0.0002950018,0.09126376,0.001955872,0.00008426267,0.0003533647,0.001070045],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9854791,0.002792631,0.0002243805,0.0000544102,0.0008113183,0.006522664,0.0001721182,0.0002407844,0.003702665],"genre_scores_gemma":[0.9908497,0.002287947,0.001786445,0.0005230613,0.0006716627,0.000516372,0.0002652233,0.0003136054,0.002785974],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1722242,"threshold_uncertainty_score":0.9998745,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2047725399","doi":"10.1016/j.clml.2013.03.020","title":"Subcutaneous Omacetaxine Mepesuccinate in Patients With Chronic-Phase Chronic Myeloid Leukemia Previously Treated With 2 or More Tyrosine Kinase Inhibitors Including Imatinib","year":2013,"lang":"en","type":"article","venue":"Clinical Lymphoma Myeloma & Leukemia","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":65,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute; University of Texas MD Anderson Cancer Center; Teva Pharmaceutical Industries","keywords":"Medicine; Nilotinib; Dasatinib; Internal medicine; Adverse effect; Gastroenterology; Imatinib; Neutropenia; Clinical endpoint; Confidence interval; Myeloid leukemia; Surgery; Randomized controlled trial; Toxicity","authors":[{"name":"Jörge E. Cortes","is_ca":false},{"name":"Franck E. Nicolini","is_ca":false},{"name":"Meir Wetzler","is_ca":false},{"name":"Jeffrey H. Lipton","is_ca":true},{"name":"Luke P. Akard","is_ca":false},{"name":"Adam Craig","is_ca":false},{"name":"Nisha Nanda","is_ca":false},{"name":"Annie-Claude Benichou","is_ca":false},{"name":"Janis Leonoudakis","is_ca":false},{"name":"H. Jean Khoury","is_ca":false},{"name":"Andreas Hochhaus","is_ca":false},{"name":"Michele Baccarani","is_ca":false},{"name":"Hagop M. Kantarjian","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01974581216089715,"gpt":0.3045457770249775,"spread":0.2847999648640803,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0008092487,0.001967635,0.003341255,0.0006944714,0.0004334437,0.0002195831,0.0008459477,0.001086297,0.001386652],"category_scores_gemma":[0.0007875328,0.0013277,0.0005391811,0.002166379,0.001158472,0.0009255944,0.0004928806,0.001328968,0.0007192899],"about_ca_system_candidate":true,"about_ca_system_consensus":true,"about_ca_system_score_codex":0.03996072,"about_ca_system_score_gemma":0.01211997,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002370193,"about_ca_topic_score_gemma":0.001044088,"domain_scores_codex":[0.9888446,0.0004825388,0.003475092,0.002730084,0.001753605,0.002714122],"domain_scores_gemma":[0.9925215,0.001002599,0.001425171,0.002530783,0.0008419021,0.001678054],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.02204357,0.003371256,0.2982164,0.001096101,0.001317882,0.008062768,0.0004073153,0.0003187657,0.001164955,0.0000240643,0.00264423,0.6613327],"study_design_scores_gemma":[0.1355815,0.02763649,0.8147627,0.004025148,0.001079184,0.001267489,0.00009882828,0.007320164,0.004031985,0.00001847941,0.002250124,0.001927967],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9893976,0.001480344,0.00003387846,0.0004677458,0.0002949927,0.006797374,0.00008972389,0.0006822905,0.0007560943],"genre_scores_gemma":[0.9914393,0.0004144385,0.001907324,0.0006327906,0.0009223809,0.0009328321,0.001071456,0.000492678,0.002186764],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.6594048,"threshold_uncertainty_score":0.9995262,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2511176690","doi":"10.1016/j.clml.2016.08.010","title":"Myelomatous Involvement of the Central Nervous System","year":2016,"lang":"en","type":"article","venue":"Clinical Lymphoma Myeloma & Leukemia","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":60,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Central nervous system; Multiple myeloma; Cerebrospinal fluid; Odds ratio; Magnetic resonance imaging; Confidence interval; Complication; Bone marrow; Cohort; Plasma cell; Internal medicine; Pathology; Gastroenterology; Radiology","authors":[{"name":"Jonas Paludo","is_ca":false},{"name":"Utkarsh Painuly","is_ca":false},{"name":"Shaji Kumar","is_ca":false},{"name":"Wilson I. Gonsalves","is_ca":false},{"name":"S. Vincent Rajkumar","is_ca":false},{"name":"Francis K. Buadi","is_ca":false},{"name":"Martha Q. Lacy","is_ca":false},{"name":"Angela Dispenzieri","is_ca":false},{"name":"Robert A. Kyle","is_ca":false},{"name":"Michelle L. Mauermann","is_ca":false},{"name":"Arleigh McCurdy","is_ca":true},{"name":"David Dingli","is_ca":false},{"name":"Ronald S. Go","is_ca":false},{"name":"Suzanne R. Hayman","is_ca":false},{"name":"Nelson Leung","is_ca":false},{"name":"John A. Lust","is_ca":false},{"name":"Yi Lin","is_ca":false},{"name":"Morie A. Gertz","is_ca":false},{"name":"Prashant Kapoor","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03741777232020433,"gpt":0.3179641029791642,"spread":0.2805463306589599,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006632818,0.0003730523,0.0009148842,0.00009906109,0.0001736299,0.0000233006,0.0005713236,0.0003218019,0.0001413026],"category_scores_gemma":[0.0009478491,0.0001823769,0.0008065763,0.0003620119,0.0007031619,0.0001060001,0.0003806348,0.0001692231,0.0003547378],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001851298,"about_ca_system_score_gemma":0.001658012,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002795193,"about_ca_topic_score_gemma":0.00003646388,"domain_scores_codex":[0.9955457,0.0003843762,0.001425665,0.0006792264,0.00100583,0.00095913],"domain_scores_gemma":[0.9962572,0.0007660904,0.0004251443,0.001496361,0.0002766707,0.0007785474],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.0009177642,0.0003660331,0.3412551,0.0002346183,0.0004308712,0.0003278106,0.00004866435,7.663259e-7,0.002696536,0.001469935,0.002105496,0.6501464],"study_design_scores_gemma":[0.008561091,0.0005576719,0.9750032,0.0009207586,0.0001696764,0.0002165471,0.00009047746,0.0001843335,0.008331556,0.0001073831,0.005651585,0.0002057197],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.991946,0.000278232,0.0001166139,0.001159648,0.0008679981,0.001082162,0.00006840673,0.0001685634,0.00431241],"genre_scores_gemma":[0.9961688,0.0001268496,0.0004498835,0.0003637447,0.0004952056,0.00007543495,0.00001366739,0.00006074737,0.002245678],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.6499407,"threshold_uncertainty_score":0.7437114,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1979590202","doi":"10.3816/clml.2010.n.079","title":"Bendamustine Produces Durable Responses With an Acceptable Safety Profile in Patients With Rituximab-Refractory Indolent Non-Hodgkin Lymphoma","year":2010,"lang":"en","type":"article","venue":"Clinical Lymphoma Myeloma & Leukemia","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":57,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Bendamustine; Medicine; Rituximab; Internal medicine; Refractory (planetary science); Gastroenterology; Salvage therapy; Chronic lymphocytic leukemia; Follicular lymphoma; Chemotherapy; Surgery; Lymphoma; Oncology; Leukemia","authors":[{"name":"Bruce D. Cheson","is_ca":false},{"name":"Jonathan W. Friedberg","is_ca":false},{"name":"Brad S. Kahl","is_ca":false},{"name":"Richard H. van der Jagt","is_ca":true},{"name":"Lothar Tremmel","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01391796457377985,"gpt":0.2928866579376173,"spread":0.2789686933638374,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001221368,0.0009202157,0.001761365,0.0003756055,0.0003477502,0.0001500274,0.0005401649,0.000645887,0.0006724917],"category_scores_gemma":[0.0007794672,0.0006245913,0.0002594136,0.0008487663,0.0007144764,0.0008023783,0.0002156483,0.0005259713,0.0002779842],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001525357,"about_ca_system_score_gemma":0.003941066,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008485492,"about_ca_topic_score_gemma":0.0009527349,"domain_scores_codex":[0.9935938,0.0003393987,0.001748245,0.001900205,0.00115619,0.001262199],"domain_scores_gemma":[0.9949422,0.0008058863,0.0006736338,0.00197736,0.0006030457,0.0009979137],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.02072369,0.008615443,0.6008028,0.00008106384,0.0002006527,0.0004329834,0.0001528393,0.000004046958,0.0001428929,0.00003787897,0.0005621338,0.3682435],"study_design_scores_gemma":[0.0540026,0.009004774,0.9225539,0.0004899871,0.000304148,0.0001216641,0.0001238899,0.0001370464,0.002940135,0.00001713443,0.009533,0.0007717108],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9935665,0.0001000607,0.000007468908,0.0004372888,0.0005306234,0.002525743,0.000163719,0.0002259933,0.002442659],"genre_scores_gemma":[0.9906576,0.00007938107,0.005597504,0.0007757843,0.0005670502,0.0004745397,0.0006570337,0.0001751168,0.001015998],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3674718,"threshold_uncertainty_score":0.9996206,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2627091086","doi":"10.1016/j.clml.2017.06.001","title":"Effects of Bosutinib Treatment on Renal Function in Patients With Philadelphia Chromosome-Positive Leukemias","year":2017,"lang":"en","type":"article","venue":"Clinical Lymphoma Myeloma & Leukemia","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":53,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre","funders":"Pfizer","keywords":"Bosutinib; Renal function; Medicine; Imatinib; Internal medicine; Oncology; Gastroenterology; Dasatinib","authors":[{"name":"Jörge E. Cortes","is_ca":false},{"name":"Carlo Gambacorti‐Passerini","is_ca":false},{"name":"Dong‐Wook Kim","is_ca":false},{"name":"Hagop M. Kantarjian","is_ca":false},{"name":"Jeff H. Lipton","is_ca":true},{"name":"Amit Lahoti","is_ca":false},{"name":"Moshe Talpaz","is_ca":false},{"name":"Ewa Matczak","is_ca":false},{"name":"Elly Barry","is_ca":false},{"name":"Eric Leip","is_ca":false},{"name":"Tim H. Brümmendorf","is_ca":false},{"name":"H. Jean Khoury","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01881039639050934,"gpt":0.2963083973831734,"spread":0.277498000992664,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003630641,0.000765214,0.001694321,0.0002631609,0.0003163149,0.00005885326,0.0004221601,0.0006160723,0.00008268739],"category_scores_gemma":[0.0008042673,0.0005685249,0.0005073663,0.0002324369,0.0007473077,0.0002894765,0.0001611696,0.0003968769,0.0002065478],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.009056215,"about_ca_system_score_gemma":0.002482553,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004218859,"about_ca_topic_score_gemma":0.0000676718,"domain_scores_codex":[0.9953877,0.0002496281,0.001411393,0.001274115,0.0008680825,0.0008090395],"domain_scores_gemma":[0.9951534,0.001056158,0.001115163,0.001891154,0.0002589647,0.0005251154],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0236773,0.004874914,0.552016,0.0002315358,0.001373822,0.001000168,0.0001825742,0.00003229158,0.0004457894,0.0001959325,0.0006289273,0.4153407],"study_design_scores_gemma":[0.06624033,0.01661116,0.9056219,0.001484183,0.0007467379,0.00002473753,0.00001226857,0.0001206976,0.007810016,0.00007121392,0.0008144338,0.0004423524],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9935518,0.0001557454,0.0000140283,0.0003021804,0.000556608,0.002112211,0.00004948241,0.0001000469,0.003157903],"genre_scores_gemma":[0.9976749,0.0001331734,0.0002514676,0.0003914128,0.0005052081,0.0001702377,0.0002255418,0.0001164268,0.0005315783],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4148984,"threshold_uncertainty_score":0.9996766,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2069385780","doi":"10.1016/j.clml.2011.03.033","title":"Addition of AEG35156 XIAP Antisense Oligonucleotide in Reinduction Chemotherapy Does Not Improve Remission Rates in Patients With Primary Refractory Acute Myeloid Leukemia in a Randomized Phase II Study","year":2011,"lang":"en","type":"article","venue":"Clinical Lymphoma Myeloma & Leukemia","topic":"Cell death mechanisms and regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":53,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Hôpital Charles-Le Moyne; Université de Montréal; Hôpital Maisonneuve-Rosemont; Aegera Therapeutics (Canada); University of Toronto; Ontario Institute for Cancer Research","funders":"","keywords":"Idarubicin; Cytarabine; Medicine; Chemotherapy; Myeloid leukemia; Internal medicine; Refractory (planetary science); XIAP; Induction chemotherapy; Gastroenterology; Oncology; Randomized controlled trial; Acute leukemia; Leukemia; Pharmacology; Surgery; Apoptosis; Caspase; Biology","authors":[{"name":"Aaron D. Schimmer","is_ca":true},{"name":"Wolfgang Herr","is_ca":false},{"name":"Mathias Hänel","is_ca":false},{"name":"G. Borthakur","is_ca":false},{"name":"Arthur E. Frankel","is_ca":false},{"name":"Heinz‐August Horst","is_ca":false},{"name":"Sonja Martin","is_ca":false},{"name":"Jeannine Kassis","is_ca":true},{"name":"Karen Seiter","is_ca":false},{"name":"Walter Fiedler","is_ca":false},{"name":"Richard Noppeney","is_ca":false},{"name":"Aristoteles Giagounidis","is_ca":false},{"name":"Christine Jacob","is_ca":true},{"name":"Jacques Jolivet","is_ca":true},{"name":"Martin S. Tallman","is_ca":false},{"name":"Steffen Koschmieder","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01252439752775815,"gpt":0.2751546296371883,"spread":0.2626302321094302,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001485811,0.0003763395,0.001041095,0.0002486262,0.00006713418,0.00001384768,0.0002158787,0.0005292735,0.00003718756],"category_scores_gemma":[0.000254641,0.0002745359,0.0002238296,0.0002823371,0.0002351623,0.0000472288,0.0001320551,0.0002418514,0.000002245052],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005571991,"about_ca_system_score_gemma":0.0005629886,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003658164,"about_ca_topic_score_gemma":0.000119543,"domain_scores_codex":[0.9962753,0.0005849039,0.001602971,0.0008673305,0.000299836,0.0003696309],"domain_scores_gemma":[0.9983048,0.0001127478,0.0007105839,0.0005910004,0.0001565276,0.0001243268],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","study_design_scores_codex":[0.1804242,0.003015892,0.0121952,0.00005014054,0.0001572698,0.0000475238,0.0005733942,0.00001878268,0.4795633,0.00001395484,0.00003824101,0.3239021],"study_design_scores_gemma":[0.2035767,0.004231797,0.5747704,0.0001825475,0.00007401742,0.000004113049,0.0001205861,0.0003175433,0.2160621,0.0001449075,0.0001062942,0.0004089638],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9977013,0.00006443392,0.00006985717,0.000017652,0.0003184599,0.001630322,0.00003292386,0.0000195705,0.0001454213],"genre_scores_gemma":[0.9974875,0.0005770286,0.0009166923,0.0001299709,0.0001383412,0.00008639426,0.0003710806,0.00005709069,0.00023593],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.5625752,"threshold_uncertainty_score":0.9999707,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3158356424","doi":"10.1016/j.clml.2021.04.013","title":"Sex Differences in Multiple Myeloma Biology but not Clinical Outcomes: Results from 3894 Patients in the Myeloma XI Trial","year":2021,"lang":"en","type":"article","venue":"Clinical Lymphoma Myeloma & Leukemia","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":52,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Institute of Cancer Research","funders":"Institute of Cancer Research; Cancer Research UK; Myeloma UK; National Cancer Research Institute; Celgene; University of Leeds; National Institute for Health and Care Research; Melanoma Research Alliance; Amgen; University of Birmingham; Cancer Research Institute","keywords":"Multiple myeloma; Dyscrasia; Lenalidomide; Incidence (geometry); Internal medicine; Disease; Cancer; Medicine; Oncology; Clinical trial; Plasma cell dyscrasia; Immunology; Plasma cell","authors":[{"name":"Sarah Bird","is_ca":true},{"name":"David A. Cairns","is_ca":false},{"name":"Tom Menzies","is_ca":false},{"name":"Kevin Boyd","is_ca":true},{"name":"Faith E. Davies","is_ca":false},{"name":"Gordon Cook","is_ca":false},{"name":"Mark T. Drayson","is_ca":false},{"name":"Walter M. Gregory","is_ca":false},{"name":"Matthew Jenner","is_ca":false},{"name":"John R Jones","is_ca":true},{"name":"Martin Kaiser","is_ca":true},{"name":"Roger G. Owen","is_ca":false},{"name":"Graham Jackson","is_ca":false},{"name":"Gareth J. Morgan","is_ca":false},{"name":"Charlotte Pawlyn","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1172578914546457,"gpt":0.3878514811505375,"spread":0.2705935896958919,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch","metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.003977279,0.0009728278,0.003279436,0.0003776404,0.00027657,0.0001625264,0.001264778,0.00154103,0.0002025797],"category_scores_gemma":[0.03480384,0.0006582863,0.001362909,0.001052832,0.001153063,0.0002438338,0.0006948339,0.001680529,0.0006349245],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001015011,"about_ca_system_score_gemma":0.002710724,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003837929,"about_ca_topic_score_gemma":0.003219772,"domain_scores_codex":[0.9841821,0.004476033,0.005523608,0.002622364,0.001428898,0.001766968],"domain_scores_gemma":[0.9709875,0.02424173,0.0008526663,0.002529243,0.0004163885,0.0009725033],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.03954709,0.003426941,0.6822549,0.00002030091,0.0003814095,0.001970397,0.0002622674,5.416754e-7,0.00003650388,0.00004297067,0.00070996,0.2713468],"study_design_scores_gemma":[0.1952961,0.002211859,0.7980563,0.0001946929,0.0001308097,0.00002419214,0.0004087301,0.0006431708,0.0001998613,0.0003676209,0.001948762,0.0005179556],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9908182,0.0002137417,0.00001461678,0.002046264,0.001926025,0.002455954,0.0009064908,0.0001351403,0.001483586],"genre_scores_gemma":[0.9902393,0.0005807599,0.001061448,0.003259599,0.001344502,0.0003334437,0.002145715,0.00009556273,0.0009397345],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2708288,"threshold_uncertainty_score":0.9997552,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2725714565","doi":"10.1016/j.clml.2017.06.020","title":"Prognostic Validation of SKY92 and Its Combination With ISS in an Independent Cohort of Patients With Multiple Myeloma","year":2017,"lang":"en","type":"article","venue":"Clinical Lymphoma Myeloma & Leukemia","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University Health Network; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Internal medicine; Oncology; Cohort; Multiple myeloma; Hazard ratio; Confidence interval","authors":[{"name":"Erik H. van Beers","is_ca":false},{"name":"Martin H. van Vliet","is_ca":false},{"name":"Rowan Kuiper","is_ca":false},{"name":"Leonie de Best","is_ca":false},{"name":"Kenneth C. Anderson","is_ca":false},{"name":"Ajai Chari","is_ca":false},{"name":"Sundar Jagannath","is_ca":false},{"name":"Andrzej Jakubowiak","is_ca":false},{"name":"Shaji Kumar","is_ca":false},{"name":"Joan Levy","is_ca":false},{"name":"Daniel Auclair","is_ca":false},{"name":"Sagar Lonial","is_ca":false},{"name":"Donna Reece","is_ca":true},{"name":"Paul G. Richardson","is_ca":false},{"name":"David S. Siegel","is_ca":false},{"name":"A. Keith Stewart","is_ca":false},{"name":"Suzanne Trudel","is_ca":true},{"name":"Ravi Vij","is_ca":false},{"name":"Todd M. Zimmerman","is_ca":false},{"name":"Rafaël Fonseca","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03228211966396329,"gpt":0.3341316169356094,"spread":0.3018494972716462,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006429516,0.0002877475,0.0008286852,0.000200808,0.0001487931,0.00004837346,0.000273394,0.0002455012,0.00002299258],"category_scores_gemma":[0.001625675,0.0002094496,0.00007829307,0.0001596539,0.0004529613,0.0004764139,0.0001400894,0.0001985271,0.000006963074],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000293584,"about_ca_system_score_gemma":0.0006087357,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000239804,"about_ca_topic_score_gemma":0.000213137,"domain_scores_codex":[0.9969903,0.0002032607,0.0009047291,0.0006263479,0.0008890431,0.0003863519],"domain_scores_gemma":[0.9968421,0.0004676277,0.0007462562,0.0008071107,0.0007444799,0.0003923894],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.004909698,0.001783069,0.9132151,0.0001892035,0.0001986507,0.00009765225,0.00009323502,0.000004812774,0.0001592012,0.00007922373,0.000004566517,0.07926556],"study_design_scores_gemma":[0.02575205,0.004758595,0.9630716,0.0004698756,0.0001698305,0.00001378022,0.00003859219,0.001831251,0.003628132,0.00005639621,0.000009048383,0.0002007909],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9973874,0.0000453209,0.00002455738,0.00006272155,0.00005778467,0.002011268,0.00005358387,0.00002662397,0.000330742],"genre_scores_gemma":[0.9986813,0.00003912934,0.0007035795,0.00002148874,0.00003786854,0.00009854116,0.0003185118,0.00004332297,0.00005625382],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.07906477,"threshold_uncertainty_score":0.8541108,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3003488950","doi":"10.1016/j.clml.2020.01.017","title":"Consensus Guidelines on the Diagnosis of Multiple Myeloma and Related Disorders: Recommendations of the Myeloma Canada Research Network Consensus Guideline Consortium","year":2020,"lang":"en","type":"review","venue":"Clinical Lymphoma Myeloma & Leukemia","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":true},"ca_institutions":"University of Alberta; University of British Columbia; Western University; University of Manitoba; London Health Sciences Centre; Vancouver General Hospital; CancerCare Manitoba; Memorial University of Newfoundland","funders":"Memorial University of Newfoundland; Queen's University; Centre Hospitalier Universitaire de Québec; Saskatchewan Cancer Agency","keywords":"Guideline; Multiple myeloma; Consensus conference; Medicine; Family medicine; Intensive care medicine; Pathology; Immunology; Internal medicine","authors":[{"name":"Debra Bergstrom","is_ca":true},{"name":"Rami Kotb","is_ca":true},{"name":"Martha Louzada","is_ca":true},{"name":"Heather J. Sutherland","is_ca":true},{"name":"Sofia Tavoularis","is_ca":false},{"name":"Christopher P. Venner","is_ca":true},{"name":"Julie Anne Côté","is_ca":false},{"name":"Richard LeBlanc","is_ca":false},{"name":"Tony Reiman","is_ca":false},{"name":"Michaël Sébag","is_ca":false},{"name":"Kevin Song","is_ca":false},{"name":"Gabriele Colasurdo","is_ca":false},{"name":"Aldo Del Col","is_ca":false},{"name":"David P. McMullen","is_ca":false},{"name":"Annette E. Hay","is_ca":false},{"name":"Nicole M.B. Laferriere","is_ca":false},{"name":"Arleigh McCurdy","is_ca":false},{"name":"Jean Roy","is_ca":false},{"name":"Julie Stakiw","is_ca":false},{"name":"Suzanne Trudel","is_ca":false},{"name":"Darrell White","is_ca":false},{"name":"Fraser W. Loveys","is_ca":false},{"name":"Edward Randell","is_ca":false},{"name":"Kamilia Rizkalla","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1785388692396007,"gpt":0.438239768301308,"spread":0.2597008990617073,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch","metaepi_narrow","sts"],"consensus_categories":[],"category_scores_codex":[0.005265792,0.001168962,0.004742422,0.0002821201,0.0008467939,0.00005934711,0.001342873,0.00109631,0.0002373494],"category_scores_gemma":[0.04652048,0.0006798761,0.001603881,0.002346692,0.003263817,0.00003407964,0.001339373,0.002099451,0.00006129133],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001497515,"about_ca_system_score_gemma":0.01747015,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.03962598,"about_ca_topic_score_gemma":0.03984613,"domain_scores_codex":[0.9830373,0.004598389,0.007066994,0.00166425,0.002090445,0.001542617],"domain_scores_gemma":[0.9570074,0.0346838,0.002501529,0.002751063,0.002052253,0.001003945],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0004970184,0.0002515797,0.004095435,0.001585311,0.001871974,0.000267923,0.0000249958,0.000009700896,8.485239e-7,0.0004610532,0.2370571,0.753877],"study_design_scores_gemma":[0.00425441,0.0008227446,0.02390226,0.01305341,0.001460161,0.0003182217,0.0002145776,0.000913766,0.00002077216,0.0003186997,0.9541667,0.0005542872],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.01815991,0.9239234,0.000002048528,0.04378815,0.001595772,0.007910425,0.00198465,0.0001094646,0.002526125],"genre_scores_gemma":[0.02245455,0.9720333,0.001119017,0.001080174,0.0007626069,0.0006917155,0.0004977997,0.0002436,0.001117271],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.7533228,"threshold_uncertainty_score":0.9995652,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1944400929","doi":"10.1016/j.clml.2015.05.007","title":"Pomalidomide and Low-Dose Dexamethasone Improves Health-Related Quality of Life and Prolongs Time to Worsening in Relapsed/Refractory Patients With Multiple Myeloma Enrolled in the MM-003 Randomized Phase III Trial","year":2015,"lang":"en","type":"article","venue":"Clinical Lymphoma Myeloma & Leukemia","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Alberta; Vancouver General Hospital","funders":"","keywords":"Pomalidomide; Medicine; Dexamethasone; Lenalidomide; Internal medicine; Multiple myeloma; Clinical endpoint; Randomized controlled trial; Refractory (planetary science); Bortezomib; Oncology; Surgery","authors":[{"name":"Katja Weisel","is_ca":false},{"name":"Meletios Α. Dimopoulos","is_ca":false},{"name":"Kevin Song","is_ca":true},{"name":"Philippe Moreau","is_ca":false},{"name":"Antonio Palumbo","is_ca":false},{"name":"Andrew R. Belch","is_ca":true},{"name":"Stephen Schey","is_ca":false},{"name":"Pieter Sonneveld","is_ca":false},{"name":"Lars Sternås","is_ca":false},{"name":"Xin Yu","is_ca":false},{"name":"Ramesh Amatya","is_ca":false},{"name":"Craig J. Gibson","is_ca":false},{"name":"Mohamed H. Zaki","is_ca":false},{"name":"Christian Jacques","is_ca":false},{"name":"Jesús F. San Miguel","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.04760729851974062,"gpt":0.3588236787743686,"spread":0.311216380254628,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.01052009,0.0005564298,0.003428589,0.0004281162,0.0001203165,0.00005643769,0.0002831989,0.0004421991,0.00002538456],"category_scores_gemma":[0.02440883,0.0003537197,0.0002814787,0.0007866609,0.0008498784,0.0002021664,0.0002157368,0.0006412563,0.00002696503],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006768205,"about_ca_system_score_gemma":0.002184562,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002039141,"about_ca_topic_score_gemma":0.0002809851,"domain_scores_codex":[0.9895399,0.004014957,0.003479714,0.001028334,0.001052439,0.0008846557],"domain_scores_gemma":[0.9881696,0.008319411,0.001076029,0.0007902216,0.0002855879,0.001359125],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.7726861,0.002874166,0.07947816,0.000106897,0.0003427054,0.000147455,0.001396176,0.000004500574,0.0001412445,0.000009485929,0.0001049586,0.1427082],"study_design_scores_gemma":[0.5539096,0.00408814,0.4399349,0.0002201678,0.00005785944,0.00001139836,0.0001725969,0.001305011,0.00002042073,0.00004196556,0.00003611899,0.0002017803],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.989181,0.0008966381,0.000009594175,0.0008657658,0.0001161709,0.008707957,0.00003702543,0.00005580798,0.0001300762],"genre_scores_gemma":[0.9970117,0.00006755871,0.001260795,0.0006710794,0.0001081226,0.0005222472,0.0001271615,0.00006421873,0.0001671411],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3604568,"threshold_uncertainty_score":0.9998915,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2961471425","doi":"10.1016/j.clml.2019.07.004","title":"Long-Term Studies Assessing Outcomes of Ibrutinib Therapy in Patients With Del(11q) Chronic Lymphocytic Leukemia","year":2019,"lang":"en","type":"article","venue":"Clinical Lymphoma Myeloma & Leukemia","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Juravinski Cancer Centre; McMaster University","funders":"Cilag; Janssen Pharmaceuticals; TG Therapeutics; H. Lundbeck A/S; BeiGene; Pharmacyclics; Genentech; Sunesis; Astellas Pharma; Exelixis; Sun Pharma; Regeneron Pharmaceuticals; F. Hoffmann-La Roche; AbbVie; Janssen Biotech; Teva Pharmaceutical Industries; Gilead Sciences; Janssen Research and Development; MorphoSys; Pfizer; Biogen; Celgene; AstraZeneca; Amgen; Alexion Pharmaceuticals; Roche; GlaxoSmithKline","keywords":"Ibrutinib; Medicine; Chronic lymphocytic leukemia; Oncology; Internal medicine; Leukemia","authors":[{"name":"Thomas J. Kipps","is_ca":false},{"name":"Graeme Fraser","is_ca":true},{"name":"Steven Coutré","is_ca":false},{"name":"Jennifer R. Brown","is_ca":false},{"name":"Jacqueline C. Barrientos","is_ca":false},{"name":"Paul M. Barr","is_ca":false},{"name":"John C. Byrd","is_ca":false},{"name":"Susan O’Brien","is_ca":false},{"name":"Marie‐Sarah Dilhuydy","is_ca":false},{"name":"Peter Hillmen","is_ca":false},{"name":"Ulrich Jaeger","is_ca":false},{"name":"Carol Moreno","is_ca":false},{"name":"Paula Cramer","is_ca":false},{"name":"Stephan Stilgenbauer","is_ca":false},{"name":"Asher Chanan‐Khan","is_ca":false},{"name":"Michelle Mahler","is_ca":false},{"name":"Mariya Salman","is_ca":false},{"name":"Karl Eckert","is_ca":false},{"name":"Isabelle G. Solman","is_ca":false},{"name":"Sriram Balasubramanian","is_ca":false},{"name":"Mei Cheng","is_ca":false},{"name":"Anil Londhe","is_ca":false},{"name":"Joi Ninomoto","is_ca":false},{"name":"Angela Howes","is_ca":false},{"name":"Danelle F. James","is_ca":false},{"name":"Michael Hallek","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.04643419086277679,"gpt":0.3793727557876246,"spread":0.3329385649248479,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001785766,0.0009673241,0.003235992,0.0005680854,0.0001395875,0.00009309498,0.0009041405,0.0007715977,0.0002671167],"category_scores_gemma":[0.001289811,0.0007067063,0.0006935218,0.00123547,0.001326374,0.0005980425,0.0005496891,0.0006876148,0.0004208386],"about_ca_system_candidate":true,"about_ca_system_consensus":true,"about_ca_system_score_codex":0.1491038,"about_ca_system_score_gemma":0.07385837,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005086615,"about_ca_topic_score_gemma":0.00009201391,"domain_scores_codex":[0.9912712,0.0005103271,0.002919374,0.001678686,0.001988981,0.001631425],"domain_scores_gemma":[0.9923714,0.002880226,0.0009648674,0.002286646,0.0008951994,0.0006016199],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.002678945,0.0003489622,0.835071,0.0006702816,0.001071767,0.0002662037,0.0001972976,0.0001922854,0.00009738119,0.00005966912,0.000175762,0.1591705],"study_design_scores_gemma":[0.1030234,0.003181414,0.8879671,0.001612882,0.00018359,0.00006548141,0.0001254305,0.002280816,0.0006657215,0.00004625734,0.0001666043,0.0006813471],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9930474,0.002336966,0.00001711935,0.00007885492,0.0007630268,0.002385767,0.00001601721,0.000195566,0.001159319],"genre_scores_gemma":[0.9958797,0.001138406,0.0004886009,0.0006656056,0.0003162377,0.00009697436,0.0001058003,0.0002120992,0.001096557],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1584892,"threshold_uncertainty_score":0.9995384,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2023428359","doi":"10.1016/j.clml.2014.12.015","title":"Outcome of Patients With Non-Hodgkin Lymphomas With Concurrent MYC and BCL2 Rearrangements Treated With CODOX-M/IVAC With Rituximab Followed by Hematopoietic Stem Cell Transplantation","year":2015,"lang":"en","type":"article","venue":"Clinical Lymphoma Myeloma & Leukemia","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Vancouver General Hospital; BC Cancer Agency; University of British Columbia","funders":"Roche","keywords":"Medicine; Internal medicine; Rituximab; Oncology; Plerixafor; Transplantation; Hematopoietic stem cell transplantation; Lymphoma; Autologous stem-cell transplantation; Vincristine; Chemoimmunotherapy; Etoposide; Progression-free survival; Cyclophosphamide; Gastroenterology; Chemotherapy","authors":[{"name":"Haowei Sun","is_ca":true},{"name":"Kerry J. Savage","is_ca":true},{"name":"Aly Karsan","is_ca":true},{"name":"Graham W. Slack","is_ca":true},{"name":"Randy D. Gascoyne","is_ca":true},{"name":"Cynthia L. Toze","is_ca":true},{"name":"Laurie H. Sehn","is_ca":true},{"name":"Yasser Abou Mourad","is_ca":true},{"name":"Michael J. Barnett","is_ca":true},{"name":"Raewyn Broady","is_ca":true},{"name":"Joseph M. Connors","is_ca":true},{"name":"Donna L. Forrest","is_ca":true},{"name":"Alina S. Gerrie","is_ca":true},{"name":"Donna E. Hogge","is_ca":true},{"name":"Sujaatha Narayanan","is_ca":true},{"name":"Thomas J. Nevill","is_ca":true},{"name":"Stephen H. Nantel","is_ca":true},{"name":"Maryse Power","is_ca":true},{"name":"Heather J. Sutherland","is_ca":true},{"name":"Diego Villa","is_ca":true},{"name":"John D. Shepherd","is_ca":true},{"name":"Kevin Song","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02383174685501354,"gpt":0.2816511669996116,"spread":0.257819420144598,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003676742,0.0008260036,0.001847424,0.0001551132,0.000131389,0.0000666964,0.000219851,0.0003058501,0.00002608235],"category_scores_gemma":[0.00001909741,0.0004847625,0.0001641075,0.0004921015,0.0006342034,0.0002637973,0.00005166903,0.0001631199,0.00003376985],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009395847,"about_ca_system_score_gemma":0.0009423646,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003398399,"about_ca_topic_score_gemma":0.00008387698,"domain_scores_codex":[0.9953939,0.0001947973,0.001338555,0.001138841,0.001257071,0.0006768161],"domain_scores_gemma":[0.996576,0.000371124,0.000768945,0.0007889676,0.0005722271,0.0009227698],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0146686,0.0039858,0.9493926,0.0004639539,0.0007642246,0.000608301,0.0005375791,0.000006128263,0.0000277704,0.00002279631,0.0008807206,0.02864156],"study_design_scores_gemma":[0.1253798,0.01352099,0.8533948,0.0009687151,0.002163129,0.0001843458,0.0003474094,0.00007120559,0.002758391,0.000003324978,0.0005888753,0.0006190458],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9955068,0.0003932969,0.0001945766,0.0001100781,0.00008932374,0.002006561,0.0002399341,0.0001183908,0.001341017],"genre_scores_gemma":[0.9971073,0.0001372003,0.001062056,0.000267132,0.0000455999,0.0002259189,0.0006449043,0.0001348467,0.0003750211],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1107112,"threshold_uncertainty_score":0.9997604,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1975530543","doi":"10.1016/j.clml.2012.05.005","title":"A Phase I Study of the Metal Ionophore Clioquinol in Patients With Advanced Hematologic Malignancies","year":2012,"lang":"en","type":"article","venue":"Clinical Lymphoma Myeloma & Leukemia","topic":"Ubiquitin and proteasome pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":43,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre; Ontario Institute for Cancer Research","funders":"","keywords":"Clioquinol; Pharmacology; Medicine; Pharmacodynamics; Refractory (planetary science); Drug; Pharmacokinetics; Internal medicine; Biology","authors":[{"name":"Aaron D. Schimmer","is_ca":true},{"name":"Yulia Jitkova","is_ca":true},{"name":"Marcela Gronda","is_ca":true},{"name":"Zezhou Wang","is_ca":true},{"name":"Joseph Brandwein","is_ca":true},{"name":"Christine Chen","is_ca":true},{"name":"Vikas Gupta","is_ca":true},{"name":"Andre C. Schuh","is_ca":true},{"name":"Karen Yee","is_ca":true},{"name":"Jian Chen","is_ca":false},{"name":"Suzanne Ackloo","is_ca":false},{"name":"Tristan D. Booth","is_ca":false},{"name":"Sharon Keays","is_ca":false},{"name":"Mark D. Minden","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02113997822657017,"gpt":0.2970695218787753,"spread":0.2759295436522052,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004741006,0.0002375881,0.000432417,0.00003961594,0.0000760527,0.000009159462,0.0004016399,0.000222403,0.00001240501],"category_scores_gemma":[0.0002234768,0.0001507897,0.0001639073,0.0002338841,0.0002342465,0.00001286535,0.0002763832,0.0001250965,0.00001075294],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00005990579,"about_ca_system_score_gemma":0.0001961813,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001189793,"about_ca_topic_score_gemma":0.00001469628,"domain_scores_codex":[0.9979213,0.0003269297,0.000693011,0.000399413,0.0002469379,0.0004123791],"domain_scores_gemma":[0.9986914,0.00006633155,0.0003277218,0.0006840094,0.0001008025,0.0001296992],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.001826711,0.005801542,0.905062,0.00003926716,0.0001229483,0.000006763155,0.00024138,0.00001089392,0.008945245,0.00009464629,0.00009165402,0.0777569],"study_design_scores_gemma":[0.01167405,0.004170443,0.9420831,0.00005104707,0.00004598117,0.000008425087,0.0002859148,0.00000626093,0.04047711,0.00002885294,0.0009322351,0.0002365787],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9981414,0.0003646528,0.000006490442,0.00001706985,0.0002604501,0.0008556625,0.00002266251,0.00001311609,0.0003184906],"genre_scores_gemma":[0.9993279,0.00001878915,0.000175977,0.0001790573,0.0001076641,0.00009530558,0.00002941033,0.00002606018,0.0000398483],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.07752032,"threshold_uncertainty_score":0.6149025,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2806039308","doi":"10.1016/j.clml.2018.05.022","title":"An Open-label, Phase II Trial of Entospletinib (GS-9973), a Selective Spleen Tyrosine Kinase Inhibitor, in Diffuse Large B-cell Lymphoma","year":2018,"lang":"en","type":"article","venue":"Clinical Lymphoma Myeloma & Leukemia","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McGill University","funders":"National Cancer Institute; Gilead Sciences","keywords":"Medicine; Internal medicine; Gastroenterology; Peripheral edema; Anemia; Hypoalbuminemia; Adverse effect; Leukopenia; Hyponatremia; Surgery; Chemotherapy","authors":[{"name":"John M. Burke","is_ca":false},{"name":"Andrei R. Shustov","is_ca":false},{"name":"James Essell","is_ca":false},{"name":"Dipti Patel‐Donnelly","is_ca":false},{"name":"Jay Yang","is_ca":false},{"name":"Robert Chen","is_ca":false},{"name":"Wei Ye","is_ca":false},{"name":"Wen Shi","is_ca":false},{"name":"Sarit Assouline","is_ca":true},{"name":"Jeff P. Sharman","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.0460260974443202,"gpt":0.3835334315622945,"spread":0.3375073341179743,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001994489,0.0009248088,0.002525766,0.0003983493,0.0003950575,0.0001405845,0.001050425,0.000885767,0.0002326135],"category_scores_gemma":[0.001187525,0.0008002249,0.0004362427,0.001241453,0.000813035,0.0005389787,0.0009095193,0.0002769998,0.0002708239],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002261968,"about_ca_system_score_gemma":0.003663708,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001055709,"about_ca_topic_score_gemma":0.0003358005,"domain_scores_codex":[0.9919349,0.0007524148,0.003071926,0.001914109,0.0009556192,0.001371014],"domain_scores_gemma":[0.9942731,0.0009162378,0.001010966,0.001989241,0.0006342186,0.001176198],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.1561668,0.3573297,0.02387852,0.0001312151,0.0004760197,0.001369284,0.0009844749,2.109196e-7,0.006051957,0.0008525265,0.0115205,0.4412388],"study_design_scores_gemma":[0.6866194,0.06169517,0.1973373,0.0004352687,0.0005041877,0.00007621074,0.0001112555,0.0005379601,0.03148809,0.0001709148,0.0203151,0.0007091924],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.989796,0.0003960413,0.00001971776,0.0004913866,0.001173494,0.003456311,0.0003285698,0.0001716595,0.004166842],"genre_scores_gemma":[0.9925147,0.00032048,0.001534046,0.001751723,0.002131963,0.0004799591,0.0004227212,0.0001635369,0.0006808666],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.5304525,"threshold_uncertainty_score":0.9994448,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2410851753","doi":"10.1016/j.clml.2016.06.001","title":"Revised International Staging System Applied to Real World Multiple Myeloma Patients","year":2016,"lang":"en","type":"article","venue":"Clinical Lymphoma Myeloma & Leukemia","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Alberta Health Services; Calgary Laboratory Services","funders":"","keywords":"Medicine; Multiple myeloma; Staging system; Real world data; Oncology; Internal medicine; Cancer; Data science","authors":[{"name":"Víctor H. Jiménez‐Zepeda","is_ca":false},{"name":"Peter Duggan","is_ca":false},{"name":"Paola Neri","is_ca":false},{"name":"Fariborz Rashid-Kolvear","is_ca":true},{"name":"Jason Tay","is_ca":false},{"name":"Nizar J. Bahlis","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03628137295759545,"gpt":0.3403525894437358,"spread":0.3040712164861404,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0008793737,0.000557804,0.001110396,0.0004981984,0.0002193987,0.00009494838,0.0006500426,0.0002805309,0.0003008681],"category_scores_gemma":[0.001784572,0.0003848311,0.0004837389,0.00057631,0.0002488228,0.0002064274,0.0004951716,0.0002399912,0.003076784],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.004026534,"about_ca_system_score_gemma":0.0008069777,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002184931,"about_ca_topic_score_gemma":0.00007856901,"domain_scores_codex":[0.994282,0.0002304958,0.00170185,0.001338487,0.001344056,0.001103133],"domain_scores_gemma":[0.9948667,0.001418901,0.000369253,0.001209356,0.0005360969,0.001599645],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.002996939,0.0003244809,0.4819785,0.00007421347,0.0003085327,0.0002321215,0.00003881184,7.944719e-7,0.0007602341,0.0005368784,0.003635567,0.509113],"study_design_scores_gemma":[0.0201737,0.0004509847,0.9521636,0.0008419245,0.00009500627,0.00001571735,0.00004099014,0.0002948486,0.001081672,0.00003408351,0.0243847,0.0004227856],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9606795,0.00002046388,0.0003905253,0.001310233,0.001111067,0.001804267,0.0001632073,0.0004757019,0.03404501],"genre_scores_gemma":[0.9878152,0.00007597569,0.003027686,0.0007883584,0.001144816,0.0003038502,0.0002110631,0.000122425,0.006510649],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.5086901,"threshold_uncertainty_score":0.9998603,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2523708385","doi":"10.1016/j.clml.2016.08.006","title":"An Evaluation of Treatment Patterns and Outcomes in Elderly Patients Newly Diagnosed With Acute Myeloid Leukemia: A Retrospective Analysis of Electronic Medical Records From US Community Oncology Practices","year":2016,"lang":"en","type":"article","venue":"Clinical Lymphoma Myeloma & Leukemia","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Group for Research in Decision Analysis","funders":"National Comprehensive Cancer Network; Takeda Oncology; Takeda Pharmaceutical Company","keywords":"Medicine; Internal medicine; Retrospective cohort study; Myeloid leukemia; Medical record; Cancer; Cohort; Pediatrics","authors":[{"name":"Esprit Ma","is_ca":false},{"name":"Vijayveer Bonthapally","is_ca":false},{"name":"Anita Chawla","is_ca":false},{"name":"Patrick Lefèbvre","is_ca":true},{"name":"Ronan Swords","is_ca":false},{"name":"Marie-Hélène Lafeuille","is_ca":false},{"name":"Jonathan Fortier","is_ca":false},{"name":"Bruno Émond","is_ca":false},{"name":"Mei Sheng Duh","is_ca":false},{"name":"Bruce J. Dezube","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.04286069260701756,"gpt":0.3989409932947389,"spread":0.3560803006877213,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.005043431,0.0005284937,0.002752149,0.0007132777,0.0001206218,0.00002326621,0.0005924135,0.0009246948,0.0003365113],"category_scores_gemma":[0.007152625,0.0003325926,0.0004140186,0.001122554,0.0009084005,0.0004327463,0.000215758,0.0008677092,0.000008083503],"about_ca_system_candidate":true,"about_ca_system_consensus":true,"about_ca_system_score_codex":0.01897968,"about_ca_system_score_gemma":0.01413734,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.04315553,"about_ca_topic_score_gemma":0.06175303,"domain_scores_codex":[0.9901793,0.004094892,0.002073546,0.001005225,0.001866378,0.0007806454],"domain_scores_gemma":[0.9870185,0.00756415,0.001976428,0.00157681,0.001208371,0.000655767],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.003105363,0.001447917,0.6309119,0.00001529887,0.004091233,0.00009675226,0.0005192321,0.000006001022,0.0002013807,0.00001371881,0.00001680161,0.3595743],"study_design_scores_gemma":[0.03493458,0.02148138,0.9314091,0.0002288868,0.006441696,0.00002051884,0.0004583662,0.004061487,0.0004013425,0.0001816825,0.000073444,0.0003074708],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9972338,0.00007832865,0.0001003841,0.0005526722,0.00009752055,0.001331812,0.0003180973,0.00004914915,0.0002382353],"genre_scores_gemma":[0.9967564,0.001677576,0.0004723057,0.0002624888,0.000101311,0.0002152346,0.0004089994,0.00006131307,0.0000443736],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3592669,"threshold_uncertainty_score":0.9999126,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1975539073","doi":"10.3816/clml.2011.n.005","title":"Efficacy and Safety of Pegylated Liposomal Doxorubicin in Combination With Bortezomib for Multiple Myeloma: Effects of Adverse Prognostic Factors on Outcome","year":2011,"lang":"en","type":"article","venue":"Clinical Lymphoma Myeloma & Leukemia","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Leukemia & Lymphoma Society of Canada","funders":"","keywords":"Bortezomib; Medicine; Multiple myeloma; Internal medicine; Regimen; Adverse effect; Oncology; Refractory (planetary science); Thalidomide; Population","authors":[{"name":"Joan Bladé","is_ca":false},{"name":"Pieter Sonneveld","is_ca":false},{"name":"Jesús F. San Miguel","is_ca":false},{"name":"Heather J. Sutherland","is_ca":true},{"name":"Roman Hájek","is_ca":false},{"name":"Arnon Nagler","is_ca":false},{"name":"Andrew Spencer","is_ca":false},{"name":"Tadeusz Robak","is_ca":false},{"name":"Keith C. Lantz","is_ca":false},{"name":"Sen Hong Zhuang","is_ca":false},{"name":"Jean‐Luc Harousseau","is_ca":false},{"name":"Robert Z. Orlowski","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.04915552958730707,"gpt":0.3304564149059167,"spread":0.2813008853186096,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005253667,0.0004296209,0.001338799,0.0003428441,0.00007776944,0.000005308894,0.0001906635,0.000369321,0.00001772773],"category_scores_gemma":[0.004440707,0.000311232,0.0002643015,0.0004038128,0.0005146549,0.0001277405,0.00009064866,0.0002591221,0.000009137316],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003772759,"about_ca_system_score_gemma":0.0004703468,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003091223,"about_ca_topic_score_gemma":0.00008016731,"domain_scores_codex":[0.9964906,0.0002405925,0.001491737,0.000689213,0.0005074461,0.0005804193],"domain_scores_gemma":[0.993456,0.004737094,0.0005166253,0.0005571416,0.000287857,0.0004452753],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.02642702,0.002834039,0.8940939,0.0007077264,0.0004019566,0.0002262702,0.0003668172,0.000003246756,0.001006268,0.0001944686,0.000010378,0.07372792],"study_design_scores_gemma":[0.06138486,0.01051178,0.9115741,0.0008135078,0.0002874024,0.00001957187,0.0000794613,0.0009114323,0.01409836,0.00004889019,0.00002512128,0.0002454846],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9953876,0.00008502495,0.00007800522,0.00003766473,0.0001361795,0.00387631,0.00004933303,0.00006303476,0.0002868194],"genre_scores_gemma":[0.9977863,0.00004508413,0.001648928,0.00004406425,0.000038939,0.0001291172,0.000156397,0.00006557361,0.00008559081],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.07348243,"threshold_uncertainty_score":0.999934,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2105740844","doi":"10.3816/clml.2010.n.078","title":"Outcome of Patients With IgD and IgM Multiple Myeloma Undergoing Autologous Hematopoietic Stem Cell Transplantation: A Retrospective CIBMTR Study","year":2010,"lang":"en","type":"article","venue":"Clinical Lymphoma Myeloma & Leukemia","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Ottawa Hospital; University Health Network","funders":"National Cancer Institute; National Heart, Lung, and Blood Institute; National Institute of Allergy and Infectious Diseases; V Foundation for Cancer Research; American Cancer Society","keywords":"Medicine; Immunoglobulin D; Multiple myeloma; Hematopoietic stem cell transplantation; Transplantation; Internal medicine; Oncology; Myeloma protein; Bone marrow; Antibody; Immunology; B cell","authors":[{"name":"Donna Reece","is_ca":true},{"name":"David H. Vesole","is_ca":false},{"name":"Smriti Shrestha","is_ca":false},{"name":"Mei-Jie Zhang","is_ca":false},{"name":"Waleska S. Pérez","is_ca":false},{"name":"Angela Dispenzieri","is_ca":false},{"name":"Giuseppe Milone","is_ca":false},{"name":"Muneer H. Abidi","is_ca":false},{"name":"Harold Atkins","is_ca":true},{"name":"Asad Bashey","is_ca":false},{"name":"Christopher Bredeson","is_ca":false},{"name":"Willem Buján Boza","is_ca":false},{"name":"César O. Freytes","is_ca":false},{"name":"Robert Peter Gale","is_ca":false},{"name":"James Gajewski","is_ca":false},{"name":"John Gibson","is_ca":false},{"name":"Gregory A. Hale","is_ca":false},{"name":"Shaji Kumar","is_ca":false},{"name":"Robert A. Kyle","is_ca":false},{"name":"Hillard M. Lazarus","is_ca":false},{"name":"Philip L. McCarthy","is_ca":false},{"name":"S Pavlovsky","is_ca":false},{"name":"Vivek Roy","is_ca":false},{"name":"Daniel J. Weisdorf","is_ca":false},{"name":"Peter H. Wiernik","is_ca":false},{"name":"Parameswaran Hari","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02449255352773468,"gpt":0.3122991664099886,"spread":0.287806612882254,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006234883,0.0005234632,0.001370082,0.0002167885,0.0002432759,0.00005241327,0.0002746716,0.0003804317,0.0000817516],"category_scores_gemma":[0.0003962649,0.0003932163,0.0002625194,0.000404147,0.0006099739,0.0001989313,0.0001307826,0.0006068128,0.00005580115],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003655291,"about_ca_system_score_gemma":0.0006994943,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001545903,"about_ca_topic_score_gemma":0.0005814864,"domain_scores_codex":[0.9955561,0.0002652956,0.001453417,0.00105786,0.0009745625,0.0006927589],"domain_scores_gemma":[0.9959108,0.001553418,0.0004668656,0.0009274089,0.0004278932,0.0007136533],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.003541727,0.002182,0.9421037,0.0003648814,0.0003826375,0.0007155399,0.0007367787,0.000001215863,0.000149204,0.00005967276,0.00002901009,0.04973357],"study_design_scores_gemma":[0.03006519,0.004604958,0.962734,0.0001292094,0.0004339362,0.0001246483,0.0005011191,0.0002150452,0.0007372815,0.00005571346,0.00004005546,0.0003588271],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9961996,0.00006868887,0.00007823035,0.00007966479,0.0002739305,0.00211219,0.0001056835,0.0001422024,0.0009398167],"genre_scores_gemma":[0.9976037,0.00004263452,0.00149988,0.00009447894,0.0001152018,0.0001038497,0.00008662748,0.00008605608,0.0003675322],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.04937474,"threshold_uncertainty_score":0.999852,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2735666722","doi":"10.1016/j.clml.2017.07.006","title":"Cardiovascular Events After Exposure to Nilotinib in Chronic Myeloid Leukemia: Long-term Follow-up","year":2017,"lang":"en","type":"article","venue":"Clinical Lymphoma Myeloma & Leukemia","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre; Toronto General Hospital; University of Toronto; University Health Network","funders":"","keywords":"Nilotinib; Myeloid leukemia; Medicine; Chronic myeloid leukaemia; Term (time); Internal medicine; Oncology; Imatinib","authors":[{"name":"Nazanin Aghel","is_ca":true},{"name":"Jeffrey H. Lipton","is_ca":true},{"name":"Eshetu G. Atenafu","is_ca":true},{"name":"Dennis Dong Hwan Kim","is_ca":true},{"name":"Diego Delgado","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03357943388702309,"gpt":0.3265050216853549,"spread":0.2929255877983319,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.002206696,0.001342559,0.003218061,0.0004538205,0.0005603188,0.00023126,0.00180664,0.001493671,0.0005673229],"category_scores_gemma":[0.002399327,0.001264726,0.002679626,0.0004880237,0.0006174929,0.0006335622,0.001343593,0.001163814,0.003261955],"about_ca_system_candidate":true,"about_ca_system_consensus":true,"about_ca_system_score_codex":0.02891776,"about_ca_system_score_gemma":0.00993309,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009221312,"about_ca_topic_score_gemma":0.001056126,"domain_scores_codex":[0.9899355,0.0004908736,0.00280208,0.002816945,0.001756182,0.002198406],"domain_scores_gemma":[0.9898584,0.000487614,0.0007186618,0.006831367,0.0003461812,0.001757815],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.002489838,0.0002794803,0.5237573,0.0003029646,0.001453439,0.005044613,0.0001764856,0.00006101605,0.000246982,0.00002034082,0.001083078,0.4650845],"study_design_scores_gemma":[0.03658669,0.001797793,0.9467103,0.001685654,0.0009788942,0.0004974696,0.00002512841,0.0001143333,0.0007796427,0.00007949765,0.009614227,0.001130372],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9856887,0.004641058,0.00008769963,0.000571725,0.00308698,0.00276699,0.00006306816,0.000313902,0.002779836],"genre_scores_gemma":[0.9861891,0.001069026,0.0006655857,0.001246492,0.002828489,0.0008041496,0.000150901,0.0003199676,0.006726291],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4639541,"threshold_uncertainty_score":0.9999325,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2283642020","doi":"10.1016/j.clml.2016.02.002","title":"Evaluating the Impact of a Switch to Nilotinib on Imatinib-Related Chronic Low-Grade Adverse Events in Patients With CML-CP: The ENRICH Study","year":2016,"lang":"en","type":"article","venue":"Clinical Lymphoma Myeloma & Leukemia","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Hôpital Maisonneuve-Rosemont; Université de Montréal; University of Toronto; Princess Margaret Cancer Centre","funders":"National Cancer Institute; University of Texas MD Anderson Cancer Center; Novartis Pharmaceuticals Corporation","keywords":"Nilotinib; Medicine; Imatinib; Adverse effect; Chronic myeloid leukaemia; Oncology; Internal medicine; Myeloid leukemia","authors":[{"name":"Jörge E. Cortes","is_ca":false},{"name":"Jeffrey H. Lipton","is_ca":true},{"name":"Carole B. Miller","is_ca":false},{"name":"Lambert Busque","is_ca":true},{"name":"Luke P. Akard","is_ca":false},{"name":"Javier Pinilla‐Ibarz","is_ca":false},{"name":"Christopher Hunt Keir","is_ca":false},{"name":"Ghulam Warsi","is_ca":false},{"name":"Felice P. Lin","is_ca":false},{"name":"Michael J. Mauro","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03791484173415468,"gpt":0.3841168110887788,"spread":0.3462019693546242,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00283037,0.0007499234,0.001369886,0.000232504,0.000217199,0.00001217758,0.0008608428,0.0003199257,0.0002800785],"category_scores_gemma":[0.002938526,0.0003150656,0.000606739,0.001198265,0.0003558049,0.0001592059,0.0003537989,0.0005522171,0.0005088351],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.01003093,"about_ca_system_score_gemma":0.004682755,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000719764,"about_ca_topic_score_gemma":0.0001242202,"domain_scores_codex":[0.992596,0.001188325,0.002354974,0.001210295,0.00160628,0.001044089],"domain_scores_gemma":[0.992478,0.003429182,0.0009610069,0.002320282,0.0003571309,0.0004543765],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.005691593,0.003419686,0.7887046,0.00003367527,0.0009642623,0.0000513681,0.0008407273,0.000445813,0.0002531641,0.00001330028,0.0002162015,0.1993656],"study_design_scores_gemma":[0.05129638,0.02244866,0.9231609,0.001260303,0.000369311,0.00002020995,0.0001680058,0.0006831575,0.0001494507,0.00006723768,0.00001778915,0.0003586099],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9929412,0.00005938748,0.000006425091,0.0004860878,0.0002934816,0.005724811,0.00003710785,0.0000919072,0.0003595842],"genre_scores_gemma":[0.9983939,0.00001660257,0.0001141198,0.0002729784,0.0002129668,0.0003524357,0.00003025059,0.0001300893,0.0004766434],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.199007,"threshold_uncertainty_score":0.9999301,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3087469327","doi":"10.1016/j.clml.2020.08.022","title":"Can Next-Generation PI3K Inhibitors Unlock the Full Potential of the Class in Patients With B-Cell Lymphoma?","year":2020,"lang":"en","type":"review","venue":"Clinical Lymphoma Myeloma & Leukemia","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"Janssen Biotech; AstraZeneca France; Servier; Incyte; AbbVie; Genentech; Bayer; Celgene; Bristol-Myers Squibb Canada; Gilead Sciences; Novartis; Roche","keywords":"Medicine; Idelalisib; Follicular lymphoma; Adverse effect; Oncology; PI3K/AKT/mTOR pathway; Clinical trial; Lymphoma; Targeted therapy; Internal medicine; Population; Cancer; Chronic lymphocytic leukemia; Ibrutinib; Leukemia","authors":[{"name":"Tycel Phillips","is_ca":false},{"name":"Jean‐Marie Michot","is_ca":false},{"name":"Vincent Ribrag","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.05178835764682573,"gpt":0.3197734926016962,"spread":0.2679851349548705,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.001461622,0.0012229,0.004205764,0.0002964355,0.0002775764,0.0001401739,0.001860178,0.001556033,0.0000624094],"category_scores_gemma":[0.001391799,0.0006513341,0.001960519,0.002144674,0.001456092,0.0001567964,0.001106625,0.001291763,0.0001668053],"about_ca_system_candidate":true,"about_ca_system_consensus":true,"about_ca_system_score_codex":0.03157977,"about_ca_system_score_gemma":0.06496993,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006641995,"about_ca_topic_score_gemma":0.0002447104,"domain_scores_codex":[0.9888944,0.001756248,0.004041745,0.001719255,0.002395051,0.001193328],"domain_scores_gemma":[0.9928737,0.001345408,0.001931586,0.002669516,0.000512431,0.0006673401],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0007604297,0.000781047,0.0003785248,0.004578797,0.0004300606,0.0002683122,0.0001003903,0.0000170399,0.000006820223,0.0000444883,0.003007469,0.9896266],"study_design_scores_gemma":[0.08569009,0.00367172,0.02688564,0.0228006,0.005256061,0.0006121698,0.0001586753,0.004733955,0.0001163988,0.00005615021,0.8479614,0.002057164],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.2581685,0.7301617,0.00000821441,0.000809061,0.002204248,0.007236608,0.0001726196,0.0001290786,0.001109959],"genre_scores_gemma":[0.2798299,0.7144387,0.0001134234,0.0008361544,0.002833791,0.0003222676,0.000515591,0.0003910798,0.0007190621],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9875695,"threshold_uncertainty_score":0.9997402,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3087419444","doi":"10.1016/j.clml.2020.09.003","title":"Quality of Life Effect of the Anti-CCR4 Monoclonal Antibody Mogamulizumab Versus Vorinostat in Patients With Cutaneous T-cell Lymphoma","year":2020,"lang":"en","type":"article","venue":"Clinical Lymphoma Myeloma & Leukemia","topic":"Cutaneous lymphoproliferative disorders research","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"Janssen Biotech; National Cancer Institute; Eisai Incorporated; National Institutes of Health; Galderma; Kyowa Hakko Kirin; Kyowa Kirin Pharmaceutical Development; Manitoba Beekeepers' Association; Portola Pharmaceuticals; Celgene; Takeda Pharmaceuticals U.S.A.; Novartis; Helsinn Therapeutics; Merck","keywords":"Medicine; Vorinostat; Monoclonal antibody; Monoclonal; Lymphoma; Oncology; Cancer research; Antibody; Internal medicine; Immunology","authors":[{"name":"Pierluigi Porcu","is_ca":false},{"name":"Stacie Hudgens","is_ca":false},{"name":"Sarah McCue Horwitz","is_ca":false},{"name":"Pietro Quaglino","is_ca":false},{"name":"Richard Cowan","is_ca":false},{"name":"Larisa J. Geskin","is_ca":false},{"name":"M. Beylot‐Barry","is_ca":false},{"name":"Lysbeth Floden","is_ca":false},{"name":"M. Bagot","is_ca":false},{"name":"Athanasios Tsianakas","is_ca":false},{"name":"Alison J. Moskowitz","is_ca":false},{"name":"Auris Huen","is_ca":false},{"name":"Brigitte Dréno","is_ca":false},{"name":"Stéphane Dalle","is_ca":false},{"name":"Dolores Caballero","is_ca":false},{"name":"Mollie Leoni","is_ca":false},{"name":"Stephen Dale","is_ca":false},{"name":"Fiona Herr","is_ca":false},{"name":"Madeleine Duvic","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03388055340965346,"gpt":0.3475230672563919,"spread":0.3136425138467384,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008626885,0.000603791,0.002309004,0.0001534117,0.0001133702,0.00002610519,0.0007976024,0.0004552272,0.00009457469],"category_scores_gemma":[0.006134448,0.0004105766,0.0007086876,0.001159872,0.001175553,0.0001165972,0.0004826604,0.0004155201,0.00005067623],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006804621,"about_ca_system_score_gemma":0.003234449,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000403707,"about_ca_topic_score_gemma":0.00004067586,"domain_scores_codex":[0.9926627,0.001354652,0.002326576,0.001059556,0.001807819,0.0007886856],"domain_scores_gemma":[0.9931756,0.003420174,0.000916474,0.001178522,0.0006114435,0.0006977557],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.05788359,0.001337541,0.881143,0.0007257125,0.0003066547,0.0001844583,0.0002412831,0.00008271177,0.0009511473,0.00003322727,0.0002044442,0.05690618],"study_design_scores_gemma":[0.05614721,0.008246353,0.9287552,0.000196108,0.0001374471,0.0000372121,0.00008609874,0.001388194,0.004431875,0.000009303641,0.0001895299,0.0003754226],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9956051,0.0002079087,0.00001800359,0.0003916083,0.0002997811,0.001900901,0.0001656152,0.0000612088,0.001349943],"genre_scores_gemma":[0.9988399,0.00007996198,0.0001905096,0.0004386922,0.0001464547,0.000026092,0.0001167761,0.00009657175,0.00006508997],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.05653076,"threshold_uncertainty_score":0.9998346,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1751193725","doi":"10.1016/j.clml.2015.06.004","title":"Central Nervous System Complications and Outcomes After Allogeneic Hematopoietic Stem Cell Transplantation","year":2015,"lang":"en","type":"article","venue":"Clinical Lymphoma Myeloma & Leukemia","topic":"Neurological Complications and Syndromes","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"Canadian Nuclear Safety Commission","keywords":"Medicine; Hazard ratio; Hematopoietic stem cell transplantation; Retrospective cohort study; Cumulative incidence; Incidence (geometry); Internal medicine; Transplantation; Confidence interval; Surgery","authors":[{"name":"Vijaya Raj Bhatt","is_ca":false},{"name":"Vamshi Balasetti","is_ca":false},{"name":"Jagar Jasem","is_ca":false},{"name":"Smith Giri","is_ca":false},{"name":"Jamés O. Armitage","is_ca":false},{"name":"Fausto R. Loberiza","is_ca":false},{"name":"R. Gregory Bociek","is_ca":false},{"name":"Philip J. Bierman","is_ca":false},{"name":"Lori J. Maness","is_ca":false},{"name":"Julie M. Vose","is_ca":false},{"name":"Pierre Fayad","is_ca":false},{"name":"Mojtaba Akhtari","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.04753207381242587,"gpt":0.3070498538989017,"spread":0.2595177800864759,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003310471,0.0002778929,0.000670674,0.0000776666,0.0001140865,0.00005070935,0.0001894909,0.0002533696,0.00001424722],"category_scores_gemma":[0.00003914865,0.0002146324,0.0002397396,0.000179371,0.0002501891,0.00008317771,0.00006728448,0.00018172,0.0001769788],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002641306,"about_ca_system_score_gemma":0.0003057468,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002197288,"about_ca_topic_score_gemma":0.000005039554,"domain_scores_codex":[0.9975039,0.0002038853,0.0009442967,0.0006228564,0.0003117353,0.0004133311],"domain_scores_gemma":[0.9978616,0.0004164932,0.0001797419,0.0006482931,0.0001511777,0.0007426549],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0006152419,0.0005230092,0.8540465,0.0005175516,0.0001207885,0.0007420654,0.0004309903,0.00002372291,0.0002398131,0.003333361,0.0008891259,0.1385179],"study_design_scores_gemma":[0.002240731,0.0003334971,0.9925379,0.00005779762,0.0002246034,0.001276752,0.0001474205,0.0004454026,0.00006556606,0.000193053,0.002255687,0.0002215599],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9924827,0.0004937928,0.000961373,0.001465805,0.0002284454,0.0005845494,0.00003697217,0.0002425408,0.003503883],"genre_scores_gemma":[0.9964704,0.00007937831,0.0009351455,0.001811035,0.00008362866,0.0001372099,0.00005433433,0.00003528986,0.000393595],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1384915,"threshold_uncertainty_score":0.8752456,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2970731184","doi":"10.1016/j.clml.2019.08.004","title":"Comparison of Time to Next Treatment, Health Care Resource Utilization, and Costs in Patients with Chronic Lymphocytic Leukemia Initiated on Front-line Ibrutinib or Chemoimmunotherapy","year":2019,"lang":"en","type":"article","venue":"Clinical Lymphoma Myeloma & Leukemia","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Group for Research in Decision Analysis","funders":"National Cancer Institute; Janssen Scientific Affairs; Sunesis; AbbVie; BeiGene; TG Therapeutics","keywords":"Medicine; Chemoimmunotherapy; Ibrutinib; Hazard ratio; Internal medicine; Ofatumumab; Rituximab; Chronic lymphocytic leukemia; Oncology; Leukemia; Confidence interval; Lymphoma","authors":[{"name":"Bruno Émond","is_ca":true},{"name":"Murali Sundaram","is_ca":false},{"name":"Hela Romdhani","is_ca":true},{"name":"Patrick Lefèbvre","is_ca":true},{"name":"Song Wang","is_ca":false},{"name":"Anthony R. Mato","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.07058158062732924,"gpt":0.3954478741314718,"spread":0.3248662935041426,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006541807,0.0007342208,0.002421891,0.000476293,0.0001366552,0.0000644777,0.0004304479,0.0005420293,0.0007242138],"category_scores_gemma":[0.0005263229,0.0005478735,0.000216432,0.0009810992,0.0004376209,0.0001762551,0.0001915718,0.0003407548,0.0006895802],"about_ca_system_candidate":true,"about_ca_system_consensus":true,"about_ca_system_score_codex":0.1931544,"about_ca_system_score_gemma":0.07092841,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002064215,"about_ca_topic_score_gemma":0.0003976923,"domain_scores_codex":[0.9937351,0.0004657765,0.002234615,0.00138179,0.001055125,0.001127551],"domain_scores_gemma":[0.9951937,0.001379602,0.0006831893,0.001544813,0.0004229844,0.0007756703],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.04848307,0.0009900515,0.1479392,0.000616468,0.0004888662,0.00009779417,0.001956099,0.001259767,0.0001028091,0.00002296593,0.002634732,0.7954081],"study_design_scores_gemma":[0.1649767,0.03599229,0.7469093,0.002904619,0.0001231348,0.00004671994,0.0004455346,0.02638092,0.001471697,0.000002528534,0.01998554,0.0007610965],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9919075,0.001821569,0.00001199182,0.0001559002,0.0001134686,0.003654092,0.00007393191,0.0001464666,0.002115051],"genre_scores_gemma":[0.9945695,0.0003974174,0.0003421064,0.001612444,0.0001712557,0.00009324419,0.0007535816,0.0001763732,0.001884063],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.794647,"threshold_uncertainty_score":0.9996973,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4377826847","doi":"10.1016/j.clml.2023.05.008","title":"Recommendations for Management of Secondary Antibody Deficiency in Multiple Myeloma","year":2023,"lang":"en","type":"review","venue":"Clinical Lymphoma Myeloma & Leukemia","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McGill University Health Centre","funders":"CSL Behring","keywords":"Hypogammaglobulinemia; Medicine; Intensive care medicine; Immunodeficiency; Primary immunodeficiency; Disease; Antibody; Immunology; Pediatrics; Internal medicine; Immune system","authors":[{"name":"Sergio Giralt","is_ca":false},{"name":"Stephen Jolles","is_ca":false},{"name":"Tessa Kerre","is_ca":false},{"name":"Hillard M. Lazarus","is_ca":false},{"name":"S. Shahzad Mustafa","is_ca":false},{"name":"Genovefa A. Papanicolaou","is_ca":false},{"name":"Roberto Ria","is_ca":false},{"name":"Donald C. Vinh","is_ca":true},{"name":"John R. Wingard","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1972499887686222,"gpt":0.4681203793617792,"spread":0.2708703905931571,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001901587,0.0008931955,0.004408717,0.0009512726,0.0001885912,0.0000464842,0.0007678388,0.0009696437,0.0001676961],"category_scores_gemma":[0.001147328,0.00075093,0.002196145,0.001585339,0.0004052401,0.0001368724,0.0005477034,0.0006881412,0.0006330435],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001675914,"about_ca_system_score_gemma":0.002934938,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001020287,"about_ca_topic_score_gemma":0.00005809642,"domain_scores_codex":[0.9919742,0.000473332,0.004067482,0.001570158,0.0006941343,0.001220717],"domain_scores_gemma":[0.9925576,0.003993008,0.001049582,0.001534346,0.0002514151,0.000614089],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0003303178,0.0008304743,0.001002551,0.03672682,0.001141284,0.0006904699,0.00002079127,3.361545e-7,7.191757e-7,0.0003453465,0.002902306,0.9560086],"study_design_scores_gemma":[0.01060294,0.0009206325,0.1169372,0.0327188,0.001750128,0.0001128743,0.0001025037,0.0002249228,0.000004164574,0.0002487082,0.8356832,0.0006939312],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.003192463,0.9806221,0.0001492008,0.0002164531,0.001111734,0.008930524,0.001499171,0.00028027,0.003998082],"genre_scores_gemma":[0.0007464446,0.982544,0.006282298,0.00007814054,0.0003003439,0.001509037,0.005165718,0.0002547996,0.003119186],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9553146,"threshold_uncertainty_score":0.9994942,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3161580798","doi":"10.1016/j.clml.2021.05.002","title":"Trajectory of Symptoms in Patients Undergoing Autologous Stem Cell Transplant for Multiple Myeloma: A Population-Based Cohort Study of Patient-Reported Outcomes","year":2021,"lang":"en","type":"article","venue":"Clinical Lymphoma Myeloma & Leukemia","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"McMaster University; Hamilton Health Sciences; Institute of Aging; Juravinski Cancer Centre","funders":"Takeda Canada; Ontario Ministry of Health and Long-Term Care; Institute for Clinical Evaluative Sciences; Janssen Pharmaceuticals; Celgene; Sanofi; Roche; Amgen","keywords":"Medicine; Multiple myeloma; Population; Cohort; Internal medicine; Odds ratio; Environmental health","authors":[{"name":"Mohammed Ebraheem","is_ca":true},{"name":"Hsien Seow","is_ca":true},{"name":"Amaris Balitsky","is_ca":true},{"name":"Gregory R. Pond","is_ca":true},{"name":"Tanya M. Wildes","is_ca":true},{"name":"Branavan Sivapathasundaram","is_ca":true},{"name":"Jonathan Sussman","is_ca":true},{"name":"Hira Mian","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02771372705732486,"gpt":0.3153239903634349,"spread":0.2876102633061101,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005661625,0.0004509216,0.001889748,0.0003242834,0.0001007303,0.00001483433,0.0002076196,0.0003727978,0.00002985456],"category_scores_gemma":[0.001023539,0.0003918778,0.0006331736,0.0005073211,0.0001335217,0.00009680994,0.00006799919,0.0002284431,0.000004999182],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008972327,"about_ca_system_score_gemma":0.001966545,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006946363,"about_ca_topic_score_gemma":0.0008077481,"domain_scores_codex":[0.9940194,0.0005020176,0.002877664,0.0009651649,0.0009852763,0.0006505078],"domain_scores_gemma":[0.9936489,0.003596679,0.0008594131,0.0009414033,0.0005677082,0.00038585],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.003472034,0.008238063,0.9094995,0.0004394235,0.000812233,0.0003932726,0.000310362,0.0001676427,0.0001041418,0.000004375472,0.00001424929,0.07654469],"study_design_scores_gemma":[0.04951668,0.004227237,0.9406328,0.0002973447,0.0004861938,0.000009037233,0.0003227241,0.002273601,0.001926326,0.00001108543,0.000009218462,0.0002877502],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.995666,0.0001024236,0.00005132001,0.00002528141,0.0003119635,0.003527952,0.0001509264,0.00007152239,0.00009256115],"genre_scores_gemma":[0.9980767,0.00001346127,0.0006780428,0.00007933009,0.00002930101,0.0002950251,0.0006642961,0.00007447059,0.00008939624],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.07625695,"threshold_uncertainty_score":0.9998533,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2055127103","doi":"10.3816/clml.2010.n.015","title":"Bortezomib as a Treatment Option in Patients With Waldenström Macroglobulinemia","year":2010,"lang":"en","type":"review","venue":"Clinical Lymphoma Myeloma & Leukemia","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Bortezomib; Medicine; Rituximab; Waldenstrom macroglobulinemia; Macroglobulinemia; Internal medicine; Oncology; Proteasome inhibitor; Multiple myeloma; Lymphoma","authors":[{"name":"Meletios Α. Dimopoulos","is_ca":false},{"name":"Christine Chen","is_ca":true},{"name":"Efstathios Kastritis","is_ca":false},{"name":"Maria Gavriatopoulou","is_ca":false},{"name":"Steven P. Treon","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.0433455937624061,"gpt":0.3944574783435849,"spread":0.3511118845811788,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.001067051,0.001744261,0.006523709,0.0006915354,0.0001587703,0.0001426703,0.0008946485,0.003318448,0.0003806083],"category_scores_gemma":[0.001263433,0.001194004,0.00185374,0.001276864,0.0009345125,0.0001913498,0.0004133661,0.001891177,0.002736389],"about_ca_system_candidate":true,"about_ca_system_consensus":true,"about_ca_system_score_codex":0.08171739,"about_ca_system_score_gemma":0.07426788,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008594824,"about_ca_topic_score_gemma":0.0001959356,"domain_scores_codex":[0.9896373,0.0006085114,0.003800079,0.002522215,0.001666374,0.001765511],"domain_scores_gemma":[0.9924098,0.001589442,0.001185855,0.002924467,0.0004595456,0.001430867],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.001597911,0.001290521,0.001582707,0.003401815,0.0005873687,0.002627498,0.00002896428,0.000001009717,1.3775e-7,0.00008919866,0.0003894682,0.9884034],"study_design_scores_gemma":[0.05166053,0.003991934,0.03192471,0.01392355,0.002248261,0.001282734,0.000009638135,0.0001701037,0.00000260636,0.0000392691,0.8935719,0.001174725],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.1748077,0.81148,0.000007086577,0.00007799891,0.001124027,0.007366879,0.000172654,0.0003387065,0.004625016],"genre_scores_gemma":[0.002525604,0.9875618,0.001284234,0.0002655223,0.001500917,0.0007568251,0.001947029,0.0004415221,0.003716545],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9872287,"threshold_uncertainty_score":0.9995303,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2019329008","doi":"10.1016/j.clml.2014.04.004","title":"Clinical Features of Patients With Philadelphia-Negative Myeloproliferative Neoplasms Complicated by Portal Hypertension","year":2014,"lang":"en","type":"article","venue":"Clinical Lymphoma Myeloma & Leukemia","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"National Center for Advancing Translational Sciences; National Cancer Institute; National Institute on Aging","keywords":"Medicine; Portal hypertension; Internal medicine; Ascites; Thrombosis; Myeloproliferative neoplasm; Gastroenterology; Polycythemia vera; Incidence (geometry); Population; Cardiology; Myelofibrosis; Cirrhosis; Bone marrow","authors":[{"name":"Matthew Yan","is_ca":true},{"name":"Holly L. Geyer","is_ca":false},{"name":"Ruben A. Mesa","is_ca":false},{"name":"Ehab Atallah","is_ca":false},{"name":"Jeannie Callum","is_ca":true},{"name":"Justyna Bartoszko","is_ca":true},{"name":"Karen Yee","is_ca":true},{"name":"Manjula Maganti","is_ca":true},{"name":"Florence Wong","is_ca":true},{"name":"Vikas Gupta","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01999936816398753,"gpt":0.2955877178174157,"spread":0.2755883496534282,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008961439,0.0008435164,0.002610455,0.0001554035,0.0002629099,0.00004821812,0.0003490727,0.0007489055,0.0001835121],"category_scores_gemma":[0.0020283,0.0005736245,0.0006847535,0.0005167281,0.001292849,0.0002031233,0.000188751,0.0006621445,0.0001433178],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003073303,"about_ca_system_score_gemma":0.000804312,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00007859673,"about_ca_topic_score_gemma":0.00003833957,"domain_scores_codex":[0.9933451,0.0007264243,0.002557827,0.001559887,0.001060284,0.0007505154],"domain_scores_gemma":[0.9920613,0.003328994,0.001171459,0.001119367,0.001368684,0.00095016],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.005597586,0.004341708,0.7862577,0.00008042051,0.001283848,0.0001252791,0.0001101615,0.000006230684,0.00008197266,0.001170996,0.02995432,0.1709897],"study_design_scores_gemma":[0.01966817,0.007177253,0.9628609,0.0003695204,0.0006276118,0.0001028574,0.00005357089,0.0004323082,0.002093361,0.0002601921,0.005762438,0.0005918413],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9917707,0.0001974095,0.000150666,0.00166804,0.0004211391,0.002047503,0.0002406211,0.0001740946,0.003329765],"genre_scores_gemma":[0.9910131,0.0002403413,0.00313757,0.003542324,0.0004611356,0.0002308556,0.0009495982,0.0001210145,0.000304112],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1766031,"threshold_uncertainty_score":0.9996715,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2411574854","doi":"10.1016/j.clml.2016.06.006","title":"Vaccination in Multiple Myeloma: Review of Current Literature","year":2016,"lang":"en","type":"review","venue":"Clinical Lymphoma Myeloma & Leukemia","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"Aurora Research Institute","keywords":"Multiple myeloma; Vaccination; Medicine; Current (fluid); Virology; Immunology; Engineering","authors":[{"name":"Andinet Alemu","is_ca":false},{"name":"John O. Richards","is_ca":false},{"name":"Martin K. Oaks","is_ca":false},{"name":"Michael A. Thompson","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1076897470261745,"gpt":0.445554923738294,"spread":0.3378651767121195,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.002117017,0.001145472,0.006646999,0.0007903815,0.00008210422,0.00004119056,0.0007552103,0.001260744,0.0004667462],"category_scores_gemma":[0.007963673,0.0007361319,0.002748376,0.001591193,0.0002352328,0.0002295778,0.000414364,0.001142539,0.0008946895],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00280384,"about_ca_system_score_gemma":0.00470767,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001492472,"about_ca_topic_score_gemma":0.0000106411,"domain_scores_codex":[0.990211,0.001352923,0.004632241,0.001584023,0.001179419,0.00104037],"domain_scores_gemma":[0.9918239,0.003085645,0.001659826,0.001905684,0.000681626,0.0008433526],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001878421,0.0005919117,0.000968661,0.1802324,0.0003448464,0.0005345293,0.000009703972,6.654602e-9,3.524331e-7,0.00007322771,0.003454294,0.8136022],"study_design_scores_gemma":[0.00400412,0.0002875171,0.04280297,0.3778717,0.0005802293,0.0001829445,0.000001002558,0.000008067513,0.000002475947,0.00004119613,0.5738353,0.000382474],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001790955,0.9927259,0.00001520485,0.0001286837,0.0008326091,0.004185835,0.0004354016,0.00009920171,0.001398082],"genre_scores_gemma":[0.0002967658,0.9949839,0.0003081882,0.0001690383,0.0009226016,0.0006175331,0.001782909,0.0001706217,0.0007485064],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.8132197,"threshold_uncertainty_score":0.9998832,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2147495729","doi":"10.1016/j.clml.2013.07.003","title":"Multiple Myeloma International Staging System: “Staging” or Simply “Aging” System?","year":2013,"lang":"en","type":"review","venue":"Clinical Lymphoma Myeloma & Leukemia","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Western University","funders":"Cedars-Sinai Medical Center","keywords":"Staging system; Medicine; Multiple myeloma; Comorbidity; Malignancy; Hematologic malignancy; Oncology; Internal medicine; TNM staging system; Cancer","authors":[{"name":"Régis Bataille","is_ca":false},{"name":"Cédric Annweiler","is_ca":true},{"name":"Olivier Beauchet","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1129323935066195,"gpt":0.4167401753694728,"spread":0.3038077818628534,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.002226938,0.002300972,0.007802446,0.001195202,0.0005625534,0.0006266092,0.002130754,0.001913784,0.0006398328],"category_scores_gemma":[0.00326972,0.001623672,0.003316008,0.001143372,0.0006817219,0.0005253527,0.001340872,0.001768076,0.007845593],"about_ca_system_candidate":true,"about_ca_system_consensus":true,"about_ca_system_score_codex":0.01236232,"about_ca_system_score_gemma":0.007772695,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008291219,"about_ca_topic_score_gemma":0.00002862512,"domain_scores_codex":[0.9847305,0.001468136,0.005729498,0.003136617,0.00251174,0.002423528],"domain_scores_gemma":[0.9864463,0.004679069,0.002259044,0.003095641,0.0009752906,0.002544716],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0005193453,0.0003976361,0.00326686,0.03965222,0.003791211,0.006696686,0.0000389636,0.000001018616,0.000001572684,0.0003047788,0.006642882,0.9386868],"study_design_scores_gemma":[0.00934718,0.0006109958,0.01366976,0.05466088,0.002881493,0.002945452,0.0003597435,0.00300744,0.000008061402,0.000004366823,0.9109928,0.001511835],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.003284293,0.958493,0.0004100288,0.0003040413,0.006970406,0.009920573,0.001130229,0.002482141,0.01700529],"genre_scores_gemma":[0.01388642,0.9598894,0.00382753,0.0003224063,0.005349926,0.002089798,0.002809856,0.00075902,0.01106564],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.937175,"threshold_uncertainty_score":0.999382,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2781661609","doi":"10.1016/j.clml.2017.12.011","title":"A Comparison of the Efficacy of Immunomodulatory-containing Regimens in Relapsed/Refractory Multiple Myeloma: A Network Meta-analysis","year":2018,"lang":"en","type":"review","venue":"Clinical Lymphoma Myeloma & Leukemia","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Queen Elizabeth II Health Sciences Centre; Dalhousie University","funders":"Janssen Pharmaceuticals","keywords":"Lenalidomide; Medicine; Internal medicine; Daratumumab; Oncology; Carfilzomib; Ixazomib; Multiple myeloma; Hazard ratio; Subgroup analysis; Pomalidomide; Progression-free survival; Meta-analysis; Chemotherapy; Confidence interval","authors":[{"name":"Meletios Α. Dimopoulos","is_ca":false},{"name":"Jonathan L. Kaufman","is_ca":false},{"name":"Darrell White","is_ca":true},{"name":"Gordon Cook","is_ca":false},{"name":"Maria Teresa Rizzo","is_ca":false},{"name":"Yingxin Xu","is_ca":false},{"name":"Kyle Fahrbach","is_ca":false},{"name":"Maren Gaudig","is_ca":false},{"name":"Mary Slavcev","is_ca":false},{"name":"Lindsay Dearden","is_ca":false},{"name":"Annette Lam","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.2118797590462149,"gpt":0.4481643213528339,"spread":0.236284562306619,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","metaepi_broad","research_integrity"],"consensus_categories":["metaepi_narrow","metaepi_broad"],"category_scores_codex":[0.003782844,0.001337298,0.01713596,0.000829409,0.0002207776,0.00003744716,0.001563544,0.001659167,0.000271328],"category_scores_gemma":[0.005565722,0.0008297683,0.01466666,0.003666307,0.00150549,0.00009579037,0.0007500837,0.00153176,0.000122721],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001806677,"about_ca_system_score_gemma":0.004467054,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005199301,"about_ca_topic_score_gemma":0.0003054889,"domain_scores_codex":[0.9850091,0.003170225,0.007132612,0.001792206,0.00155347,0.001342327],"domain_scores_gemma":[0.980073,0.00991035,0.004645431,0.004194208,0.0005544438,0.0006225192],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.001909705,0.002424329,0.07138459,0.004071806,0.2234848,0.0002070967,0.0002052117,0.00005595941,0.000002242498,0.00005174109,0.0009164311,0.6952862],"study_design_scores_gemma":[0.009414127,0.001783682,0.534814,0.004709184,0.295132,0.00005061724,0.00005159493,0.000664461,0.00001565071,0.00002398821,0.152576,0.0007647518],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"empirical","genre_scores_codex":[0.05890362,0.9364721,0.0000124299,0.00003255232,0.000449188,0.00321905,0.0001567753,0.00006732882,0.0006869732],"genre_scores_gemma":[0.5309739,0.4654028,0.001150333,0.00007995577,0.0006401705,0.0003966682,0.0003880367,0.0002335999,0.0007345395],"genre_candidate":"review","genre_consensus":null,"teacher_disagreement_score":0.6945214,"threshold_uncertainty_score":0.9999378,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4323353350","doi":"10.1016/j.clml.2023.03.002","title":"Response to COVID-19 Vaccination Post-CAR T Therapy in Patients With Non-Hodgkin Lymphoma and Multiple Myeloma","year":2023,"lang":"en","type":"article","venue":"Clinical Lymphoma Myeloma & Leukemia","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"Loxo Oncology; Pharmacyclics; Kite Pharma; Genentech; National Cancer Institute; Gilead Sciences; Servier; Alexion Pharmaceuticals; Apellis Pharmaceuticals; BeiGene; Pfizer; Incyte; Innovent Biologics; Adaptive Biotechnologies; Sierra Oncology; CTI Biopharma; bluebird bio; TG Therapeutics; Regeneron Pharmaceuticals; Sanofi; Amgen; AstraZeneca; Cidara Therapeutics; MorphoSys; Celgene; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Medicine; Vaccination; Seroconversion; Lymphoma; Immunology; Multiple myeloma; Antibody; Cancer; Chimeric antigen receptor; Immune system; Immunotherapy; Virology; Internal medicine","authors":[{"name":"Julia E. Wiedmeier","is_ca":false},{"name":"Madiha Iqbal","is_ca":false},{"name":"Allison Rosenthal","is_ca":false},{"name":"Evandro D. Bezerra","is_ca":false},{"name":"Juan Esteban García-Robledo","is_ca":false},{"name":"Radhika Bansal","is_ca":false},{"name":"Patrick B. Johnston","is_ca":false},{"name":"Matthew Hathcock","is_ca":false},{"name":"Jeremy T. Larsen","is_ca":false},{"name":"P. Leif Bergsagel","is_ca":false},{"name":"Yucai Wang","is_ca":false},{"name":"Craig B. Reeder","is_ca":false},{"name":"José F. Leis","is_ca":false},{"name":"Rafaël Fonseca","is_ca":false},{"name":"Jeanne Palmer","is_ca":false},{"name":"Brianna J. Negaard","is_ca":false},{"name":"Raphael Mwangi","is_ca":false},{"name":"Rahma Warsame","is_ca":false},{"name":"Taxiarchis Kourelis","is_ca":false},{"name":"Suzanne R. Hayman","is_ca":false},{"name":"David Dingli","is_ca":false},{"name":"Prashant Kapoor","is_ca":false},{"name":"Shaji Kumar","is_ca":false},{"name":"Urshila Durani","is_ca":false},{"name":"José C. Villasboas","is_ca":false},{"name":"Jonas Paludo","is_ca":false},{"name":"N. Nora Bennani","is_ca":false},{"name":"Grzegorz S. Nowakowski","is_ca":false},{"name":"Stephen M. Ansell","is_ca":false},{"name":"Januario E. Castro","is_ca":false},{"name":"Mohamed A. Kharfan‐Dabaja","is_ca":false},{"name":"Yi Lin","is_ca":false},{"name":"Paschalis Vergidis","is_ca":false},{"name":"Hemant S. Murthy","is_ca":false},{"name":"Javier Muñoz","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03695353903935361,"gpt":0.3572703254441805,"spread":0.3203167864048269,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.003673817,0.00055433,0.001081483,0.001008312,0.0002372232,0.0001082603,0.0004540397,0.0005597287,0.0005093696],"category_scores_gemma":[0.005981316,0.0004675357,0.0002516661,0.002163569,0.0002590103,0.0002296945,0.0003304053,0.0003281375,0.0004744862],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002633385,"about_ca_system_score_gemma":0.002871582,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000434583,"about_ca_topic_score_gemma":0.0002094165,"domain_scores_codex":[0.9941106,0.0009341298,0.001278053,0.001387597,0.001216582,0.001072977],"domain_scores_gemma":[0.9924431,0.004119811,0.0002330553,0.001207849,0.000520679,0.001475547],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.06041803,0.0003920061,0.431937,0.00004803986,0.0001047518,0.0003768191,0.000650359,0.00002348711,0.004270698,0.000007019893,0.0017803,0.4999915],"study_design_scores_gemma":[0.04294798,0.006424471,0.9246277,0.0001195263,0.00002823956,0.00004122586,0.0002196537,0.001064223,0.0008199151,0.00005025497,0.02315609,0.0005006971],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9917942,0.00006727169,0.00003562278,0.004348734,0.0002755628,0.002760021,0.00006434229,0.0003269323,0.0003273295],"genre_scores_gemma":[0.989073,0.0002165287,0.0004451853,0.007066525,0.0002479073,0.0001850512,0.0002210454,0.0001718079,0.002372927],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4994908,"threshold_uncertainty_score":0.9997776,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2980239934","doi":"10.1016/j.clml.2019.09.618","title":"Adherence to Lenalidomide in Older Adults With Newly Diagnosed Multiple Myeloma","year":2019,"lang":"en","type":"article","venue":"Clinical Lymphoma Myeloma & Leukemia","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Juravinski Cancer Centre; McMaster University","funders":"National Center for Advancing Translational Sciences; National Center for Research Resources; National Institutes of Health; Agency for Healthcare Research and Quality; National Cancer Institute; Institute of Translational Health Sciences, University of Washington; Centers for Medicare and Medicaid Services","keywords":"Lenalidomide; Multiple myeloma; Medicine; Internal medicine; Oncology","authors":[{"name":"Hira Mian","is_ca":true},{"name":"Mark A. Fiala","is_ca":false},{"name":"Tanya M. Wildes","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02879022313772613,"gpt":0.3314337427988169,"spread":0.3026435196610908,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0007859058,0.0006786096,0.001521758,0.0003934579,0.0001060809,0.0000859844,0.0005679096,0.0004857731,0.0007585086],"category_scores_gemma":[0.001963052,0.0005194365,0.0004121438,0.0009286493,0.0002652988,0.0002861764,0.0002988646,0.000567965,0.004824453],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00126617,"about_ca_system_score_gemma":0.00170561,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001644997,"about_ca_topic_score_gemma":0.001232838,"domain_scores_codex":[0.9939483,0.0003313247,0.001498677,0.001663122,0.001102845,0.001455742],"domain_scores_gemma":[0.9941085,0.002172724,0.0002717511,0.001546026,0.0003219324,0.001579098],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.01377547,0.0007718876,0.5763456,0.0001394471,0.0001498513,0.002241523,0.0002624996,0.00002409965,0.000210629,0.00002846012,0.0009623511,0.4050882],"study_design_scores_gemma":[0.05859916,0.003922181,0.9291887,0.001724817,0.00006294429,0.0001522034,0.0003261939,0.001807995,0.001190987,0.00002220207,0.002432297,0.0005703762],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9916449,0.0002391281,0.00007064734,0.0005398647,0.0003648491,0.003784091,0.00004264046,0.0002033997,0.003110451],"genre_scores_gemma":[0.9898478,0.0001147161,0.004544747,0.001766772,0.0003485125,0.0004817755,0.0001397241,0.0001317921,0.002624183],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4045178,"threshold_uncertainty_score":0.9997257,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3188942243","doi":"10.1016/j.clml.2021.07.028","title":"Management of Myeloma Manifestations and Complications: The Cornerstone of Supportive Care: Recommendation of the Canadian Myeloma Research Group (formerly Myeloma Canada Research Network) Consensus Guideline Consortium","year":2021,"lang":"en","type":"review","venue":"Clinical Lymphoma Myeloma & Leukemia","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"University of British Columbia; London Health Sciences Centre; Vancouver General Hospital; CancerCare Manitoba; Memorial University of Newfoundland; University of Manitoba; Centre hospitalier universitaire de Québec; Université de Montréal; Western University; Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Guideline; Multiple myeloma; Medicine; Family medicine; Intensive care medicine; Disease; Internal medicine; Pathology","authors":[{"name":"Richard LeBlanc","is_ca":true},{"name":"Debra Bergstrom","is_ca":true},{"name":"Julie Anne Côté","is_ca":true},{"name":"Rami Kotb","is_ca":true},{"name":"Martha Louzada","is_ca":true},{"name":"Heather J. Sutherland","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1755803312582497,"gpt":0.460361134728241,"spread":0.2847808034699913,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","sts"],"consensus_categories":["sts"],"category_scores_codex":[0.008365914,0.0008370556,0.003343023,0.0007012377,0.001495199,0.0000884948,0.001447655,0.0008449783,0.0002336424],"category_scores_gemma":[0.002897136,0.0005765242,0.0009483884,0.003500482,0.004619808,0.0000869416,0.001224801,0.001930892,0.00002104112],"about_ca_system_candidate":true,"about_ca_system_consensus":true,"about_ca_system_score_codex":0.006064024,"about_ca_system_score_gemma":0.03588663,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.519768,"about_ca_topic_score_gemma":0.7715588,"domain_scores_codex":[0.9834907,0.004978832,0.005423488,0.001554813,0.002559693,0.001992445],"domain_scores_gemma":[0.9807872,0.00773704,0.002039811,0.002892099,0.005368893,0.001175027],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0002509382,0.0002543645,0.002323697,0.006651922,0.002268233,0.0005127853,0.00016652,0.000003686019,0.000001902506,0.005651086,0.03001039,0.9519045],"study_design_scores_gemma":[0.003272462,0.0008607512,0.300193,0.01373115,0.001724743,0.0006264345,0.003610684,0.0001645415,0.00001732985,0.0002823294,0.6749747,0.0005418013],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.01604137,0.9408071,0.00002162286,0.005940265,0.001072868,0.0136347,0.004011052,0.00005281182,0.01841821],"genre_scores_gemma":[0.2193015,0.7688244,0.002625461,0.0002671064,0.0004512679,0.001155214,0.005787055,0.0002363314,0.001351617],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9513627,"threshold_uncertainty_score":0.9998047,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1963599260","doi":"10.1016/j.clml.2013.05.012","title":"A Critical Review of Trials of First-Line BCR-ABL Inhibitor Treatment in Patients With Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase","year":2013,"lang":"en","type":"review","venue":"Clinical Lymphoma Myeloma & Leukemia","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre","funders":"National Cancer Institute","keywords":"Nilotinib; Dasatinib; Imatinib; Medicine; Tyrosine-kinase inhibitor; Myeloid leukemia; Tyrosine kinase; Internal medicine; Clinical trial; Oncology; Pharmacology; Cancer","authors":[{"name":"Elias Jabbour","is_ca":false},{"name":"Jeffrey H. Lipton","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.08339020883833671,"gpt":0.4046808406504899,"spread":0.3212906318121532,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch","metaepi_narrow","metaepi_broad","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.004199227,0.002731913,0.02306192,0.001246938,0.00009528667,0.0000471161,0.001098008,0.00240804,0.001368203],"category_scores_gemma":[0.01612781,0.001910362,0.004123301,0.002418895,0.001420814,0.0004090618,0.0004469083,0.001430998,0.0003049506],"about_ca_system_candidate":true,"about_ca_system_consensus":true,"about_ca_system_score_codex":0.096985,"about_ca_system_score_gemma":0.05879513,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001753883,"about_ca_topic_score_gemma":0.0007330528,"domain_scores_codex":[0.9748176,0.002947692,0.01559931,0.002851635,0.001807259,0.001976443],"domain_scores_gemma":[0.9737307,0.0151163,0.005574789,0.003555898,0.0008484778,0.001173834],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"systematic_review","study_design_scores_codex":[0.001276689,0.003796838,0.001453077,0.1351112,0.001332219,0.0006923304,0.00003675393,0.000007868361,0.000001577995,0.0000281229,0.001229721,0.8550336],"study_design_scores_gemma":[0.107361,0.01908886,0.01090631,0.4723766,0.008458938,0.00009980021,0.000007992053,0.0001613787,0.00004101308,0.00002310773,0.3799087,0.00156623],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.03453264,0.9481316,0.00001032854,0.0001165723,0.0006789708,0.01532978,0.0007914922,0.000109342,0.000299253],"genre_scores_gemma":[0.003901159,0.9870268,0.0007945888,0.0002013891,0.001409316,0.003343392,0.00259955,0.0004454562,0.0002783101],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.8534674,"threshold_uncertainty_score":0.9995447,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1986307017","doi":"10.1016/j.clml.2012.01.003","title":"Detection of CD34, TdT, CD56, CD2, CD4, and CD14 by Flow Cytometry Is Associated With NPM1 and FLT3 Mutation Status in Cytogenetically Normal Acute Myeloid Leukemia","year":2012,"lang":"en","type":"article","venue":"Clinical Lymphoma Myeloma & Leukemia","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Occupational Cancer Research Centre; Vancouver General Hospital","funders":"BC Cancer Agency; University of British Columbia","keywords":"NPM1; CD34; Flow cytometry; CD19; Myeloid leukemia; CD33; CD14; Mutation; Gene mutation; Leukemia; Medicine; Molecular biology; Cancer research; Myeloid; Internal medicine; Immunology; Oncology; Biology; Gene; Karyotype; Genetics; Stem cell","authors":[{"name":"Bakul I. Dalal","is_ca":true},{"name":"Soudeh Mansoor","is_ca":true},{"name":"Mita Manna","is_ca":true},{"name":"Steven Pi","is_ca":true},{"name":"Giovanna Di Sauro","is_ca":true},{"name":"Donna E. Hogge","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01838067840154703,"gpt":0.3085404674738134,"spread":0.2901597890722664,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.002720669,0.000710912,0.001630464,0.0006361459,0.0002086127,0.00008414044,0.0002925181,0.001177127,0.00009945372],"category_scores_gemma":[0.002286706,0.0006305685,0.0002452547,0.001540319,0.00124668,0.0006040601,0.0003705687,0.001048638,0.00005262685],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.003923771,"about_ca_system_score_gemma":0.002190395,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004011715,"about_ca_topic_score_gemma":0.000115487,"domain_scores_codex":[0.9932731,0.0006919291,0.001932331,0.001155463,0.001237046,0.001710078],"domain_scores_gemma":[0.9948928,0.00176659,0.0006191343,0.0007922432,0.0005189405,0.001410235],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.004187319,0.0004948634,0.4813279,0.0002269915,0.0009509725,0.0003868892,0.0008037722,0.00001281524,0.03729606,0.00002997015,0.001274739,0.4730078],"study_design_scores_gemma":[0.01471507,0.00226844,0.9540532,0.0002924876,0.0005512031,0.0006875112,0.0002648179,0.009295472,0.01601998,0.00006734533,0.001131571,0.0006528642],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9946331,0.001428975,0.001257492,0.0002586427,0.0002140233,0.001055505,0.0002139651,0.00014008,0.0007981806],"genre_scores_gemma":[0.9933832,0.001188267,0.003115644,0.0009118202,0.0003412423,0.00008853806,0.0002737949,0.0001555038,0.0005420371],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4727254,"threshold_uncertainty_score":0.9999,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1973979329","doi":"10.1016/j.clml.2014.07.015","title":"A Canadian Evidence-Based Guideline for the First-Line Treatment of Follicular Lymphoma: Joint Consensus of the Lymphoma Canada Scientific Advisory Board","year":2014,"lang":"en","type":"review","venue":"Clinical Lymphoma Myeloma & Leukemia","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"University of British Columbia; Queen Elizabeth II Health Sciences Centre; University of Calgary; McGill University; University of Toronto; Dalhousie University; BC Cancer Agency; Princess Margaret Cancer Centre; Jewish General Hospital","funders":"","keywords":"Guideline; Follicular lymphoma; Medicine; Lymphoma; Family medicine; Disease; Executive summary; Intensive care medicine; Front line; Internal medicine; Political science; Pathology","authors":[{"name":"John Kuruvilla","is_ca":true},{"name":"Sarit Assouline","is_ca":true},{"name":"David Hodgson","is_ca":true},{"name":"David MacDonald","is_ca":true},{"name":"Doug Stewart","is_ca":true},{"name":"Anna Christofides","is_ca":false},{"name":"Marina Komolova","is_ca":false},{"name":"Joseph Connors","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1035812907999964,"gpt":0.3549666461944209,"spread":0.2513853553944245,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.002549976,0.001670018,0.0070008,0.0004314508,0.0008931652,0.0001099387,0.001412558,0.0011399,0.00009908345],"category_scores_gemma":[0.00385755,0.000893511,0.005853558,0.001279029,0.001681128,0.00005540691,0.0002344674,0.0001518062,0.00003480941],"about_ca_system_candidate":true,"about_ca_system_consensus":true,"about_ca_system_score_codex":0.02072353,"about_ca_system_score_gemma":0.1078092,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.7477101,"about_ca_topic_score_gemma":0.7807855,"domain_scores_codex":[0.9876653,0.0007736765,0.006590395,0.001961394,0.001557945,0.001451283],"domain_scores_gemma":[0.9799258,0.00920817,0.003600045,0.004700962,0.001332366,0.001232716],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0003132251,0.0009844113,0.001035678,0.004966446,0.002201692,0.0002253741,0.00002390217,0.00004470251,7.739827e-7,0.0001192542,0.04014608,0.9499385],"study_design_scores_gemma":[0.01169449,0.001559461,0.02181607,0.01809071,0.01080243,0.0002284158,0.0000270579,0.001066612,0.0001657553,0.00002866712,0.9337709,0.0007494161],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.01183678,0.9691123,0.0000266912,0.005704411,0.003496351,0.008010834,0.001579731,0.00006020298,0.0001727375],"genre_scores_gemma":[0.06913733,0.920889,0.0008033979,0.003055017,0.001434284,0.002409284,0.0007155454,0.0003457825,0.001210415],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9491891,"threshold_uncertainty_score":0.9996046,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2943115873","doi":"10.1016/j.clml.2019.04.014","title":"Geriatric Assessment and Frailty Scores Predict Mortality in Myeloma: Systematic Review and Meta-analysis","year":2019,"lang":"en","type":"review","venue":"Clinical Lymphoma Myeloma & Leukemia","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McMaster University; Juravinski Cancer Centre","funders":"American Society of Clinical Oncology; Janssen Biotech; National Cancer Institute; Foundation for the National Institutes of Health","keywords":"Medicine; Meta-analysis; Hazard ratio; Multiple myeloma; Internal medicine; Confidence interval; Incidence (geometry); Adverse effect","authors":[{"name":"Ana S. Salazar","is_ca":false},{"name":"Luisa Recinos","is_ca":false},{"name":"Hira Mian","is_ca":true},{"name":"C Stoll","is_ca":false},{"name":"Laura Simon","is_ca":false},{"name":"Subhjit Sekhon","is_ca":false},{"name":"Graham A. Colditz","is_ca":false},{"name":"Tanya M. Wildes","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.2212138162500832,"gpt":0.4785600637822102,"spread":0.257346247532127,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.004980954,0.001533697,0.02652331,0.0009815211,0.0001390947,0.0001706949,0.0006129316,0.00115926,0.0003686978],"category_scores_gemma":[0.002307482,0.0009633676,0.00579384,0.002171116,0.0004864243,0.0002138049,0.0007182838,0.001084047,0.0001700516],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001699419,"about_ca_system_score_gemma":0.003436283,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000292187,"about_ca_topic_score_gemma":0.00009065809,"domain_scores_codex":[0.98626,0.003165282,0.005645737,0.002444885,0.001426679,0.001057398],"domain_scores_gemma":[0.9898181,0.003844522,0.001992523,0.002881276,0.0002658318,0.001197765],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.00002935864,0.0003068678,0.00612088,0.6952391,0.1818519,0.000688773,0.000006016248,1.149664e-7,2.320119e-8,0.00003783846,0.0001986593,0.1155205],"study_design_scores_gemma":[0.001823089,0.0003466742,0.2181212,0.03442813,0.7391127,0.0002360831,0.000005059183,0.00009136782,5.172165e-8,0.00002142674,0.005199255,0.000614979],"study_design_candidate":"meta_analysis","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.001315631,0.9862022,0.00001314902,0.000105624,0.000107397,0.01104826,0.0005150865,0.0000989937,0.0005936344],"genre_scores_gemma":[0.001932554,0.992677,0.0005109343,0.0004576906,0.00012943,0.002081094,0.000824141,0.0001369686,0.001250171],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.660811,"threshold_uncertainty_score":0.9997411,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4226022053","doi":"10.1016/j.clml.2021.12.003","title":"An Overview of CAR T Cell Mediated B Cell Maturation Antigen Therapy","year":2021,"lang":"en","type":"review","venue":"Clinical Lymphoma Myeloma & Leukemia","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Emergent BioSolutions (Canada)","funders":"","keywords":"Chimeric antigen receptor; Multiple myeloma; Medicine; Malignancy; Plasma cell; Antigen; Cancer research; Antibody; Clinical trial; Cancer; Immunology; Oncology; Immunotherapy; Internal medicine","authors":[{"name":"Sameer Quazi","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1708511973895735,"gpt":0.4525105370994986,"spread":0.2816593397099251,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.002381755,0.001072942,0.006511242,0.0004016286,0.0001141614,0.00009892142,0.001033604,0.00224163,0.004283728],"category_scores_gemma":[0.00046682,0.0008584643,0.00295525,0.001436586,0.0004787234,0.0001706996,0.0002369031,0.001234147,0.0005044041],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001310487,"about_ca_system_score_gemma":0.00952791,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001247237,"about_ca_topic_score_gemma":0.000008006579,"domain_scores_codex":[0.989993,0.002312588,0.003718234,0.001657133,0.001413701,0.0009052983],"domain_scores_gemma":[0.9916521,0.002346402,0.001471654,0.002885298,0.000735286,0.0009092683],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0003215552,0.0008090205,0.0001222271,0.01113911,0.000462887,0.0004533564,0.00006405373,3.023061e-7,0.00114315,0.00002000677,0.002119622,0.9833447],"study_design_scores_gemma":[0.003729234,0.001281242,0.005669919,0.007984215,0.0007671512,0.0001561983,0.0000362473,0.0000532754,0.0008729284,0.0000145504,0.9786893,0.0007457683],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.01326872,0.9796699,0.000006876543,0.0000385366,0.0008013127,0.002327001,0.0001652956,0.0001539654,0.00356834],"genre_scores_gemma":[0.0004565073,0.9900277,0.0004357914,0.0004120301,0.00151131,0.0001274255,0.003101722,0.0003397226,0.003587804],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.982599,"threshold_uncertainty_score":0.9993866,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2776794568","doi":"10.1016/j.clml.2017.12.004","title":"The Effect of Lenalidomide on Health-Related Quality of Life in Patients With Lower-Risk Non-del(5q) Myelodysplastic Syndromes: Results From the MDS-005 Study","year":2017,"lang":"en","type":"article","venue":"Clinical Lymphoma Myeloma & Leukemia","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Lenalidomide; Medicine; Placebo; Myelodysplastic syndromes; Discontinuation; Quality of life (healthcare); Internal medicine; International Prognostic Scoring System; Anemia; Randomized controlled trial; Physical therapy; Multiple myeloma; Bone marrow","authors":[{"name":"Valeria Santini","is_ca":false},{"name":"António Almeida","is_ca":false},{"name":"Aristoteles Giagounidis","is_ca":false},{"name":"Uwe Platzbecker","is_ca":false},{"name":"Rena Buckstein","is_ca":true},{"name":"C. L. Beach","is_ca":false},{"name":"Shien Guo","is_ca":false},{"name":"Arman Altincatal","is_ca":false},{"name":"Chengqing Wu","is_ca":false},{"name":"Pierre Fenaux","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.0369554667939113,"gpt":0.3581188018206333,"spread":0.321163335026722,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.01348638,0.0006824341,0.002924146,0.0001575728,0.000841033,0.00009523518,0.001989375,0.0005143677,0.00002372706],"category_scores_gemma":[0.04609714,0.000349066,0.0005439296,0.0004983283,0.002065858,0.0001775233,0.0006611667,0.001589677,0.0001105225],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001646017,"about_ca_system_score_gemma":0.003465025,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.01678388,"about_ca_topic_score_gemma":0.001417524,"domain_scores_codex":[0.9868736,0.004255143,0.004488927,0.001306845,0.002054311,0.001021231],"domain_scores_gemma":[0.9610654,0.02907578,0.004038172,0.004749554,0.0004166135,0.0006545002],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.08599262,0.001030306,0.8323872,0.0001054936,0.0009698396,0.0000921808,0.0004382987,0.00005812866,0.00000851657,0.00001434251,0.002151957,0.07675112],"study_design_scores_gemma":[0.0713485,0.0173127,0.9087258,0.001049951,0.0002350197,0.000003992751,0.0002433183,0.0005716734,0.00005200125,0.00005153929,0.000108497,0.0002970228],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9925628,0.0001868457,0.000006251877,0.001804639,0.000609976,0.003931496,0.0003281513,0.00004959474,0.0005202555],"genre_scores_gemma":[0.9988047,0.0001927701,0.00005549482,0.0002436885,0.0002180398,0.0001013229,0.00009968445,0.0001032343,0.0001810397],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0764541,"threshold_uncertainty_score":0.9998961,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2055073381","doi":"10.1016/j.clml.2013.09.010","title":"A Comparison of Long-Term Outcomes of Donor Lymphocyte Infusions and Tyrosine Kinase Inhibitors in Patients With Relapsed CML After Allogeneic Hematopoietic Cell Transplantation","year":2013,"lang":"en","type":"article","venue":"Clinical Lymphoma Myeloma & Leukemia","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University Health Network; Princess Margaret Cancer Centre","funders":"","keywords":"Hematopoietic cell; Tyrosine kinase; Medicine; Lymphocyte; Hematopoietic stem cell transplantation; Haematopoiesis; Immunology; Transplantation; Term (time); Oncology; Cancer research; Internal medicine; Stem cell; Biology; Receptor; Genetics","authors":[{"name":"Mohamed Shanavas","is_ca":true},{"name":"Hans A. Messner","is_ca":true},{"name":"Suzanne Kamel‐Reid","is_ca":true},{"name":"Eshetu G. Atenafu","is_ca":true},{"name":"Vikas Gupta","is_ca":true},{"name":"John Kuruvilla","is_ca":true},{"name":"Dennis Dong Hwan Kim","is_ca":true},{"name":"Jieun Uhm","is_ca":true},{"name":"Anna Lambie","is_ca":true},{"name":"Laura Ellis","is_ca":true},{"name":"Jeffrey H. Lipton","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.0172757160603624,"gpt":0.2979828592730306,"spread":0.2807071432126683,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002271639,0.00045458,0.00152316,0.0002625844,0.00004678531,0.00001700827,0.0001670823,0.0004014021,0.0001403427],"category_scores_gemma":[0.0001248031,0.0003456004,0.0002425353,0.0003696872,0.0004880377,0.0001925533,0.00009704426,0.000203759,0.0000373683],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001099479,"about_ca_system_score_gemma":0.0008911499,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004285678,"about_ca_topic_score_gemma":0.0001432413,"domain_scores_codex":[0.9962265,0.0001629662,0.001979453,0.0006404307,0.0005420556,0.0004485554],"domain_scores_gemma":[0.9975137,0.0005646015,0.0006560546,0.0006739756,0.0002340936,0.0003575615],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.002285896,0.001587,0.9384838,0.0006131288,0.0001416637,0.00009360316,0.0005067305,0.00001107712,0.0006200752,0.000003929269,0.00003826253,0.05561483],"study_design_scores_gemma":[0.03206019,0.001539651,0.9583008,0.0008843946,0.0004531337,0.00002108231,0.0000505909,0.00007679965,0.006296476,0.00001195924,0.00000752417,0.0002973855],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.997339,0.0007462543,0.00001409654,0.0000700653,0.0001454599,0.001480718,0.00004106351,0.00004064398,0.0001227561],"genre_scores_gemma":[0.9981558,0.0002253415,0.0009251913,0.0001631043,0.00003543428,0.0001391393,0.0001853513,0.00006382479,0.0001068393],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.05531745,"threshold_uncertainty_score":0.9998996,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4389623269","doi":"10.1016/j.clml.2023.12.005","title":"Mosunetuzumab Safety Profile in Patients With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma: Clinical Management Experience From a Pivotal Phase I/II Trial","year":2023,"lang":"en","type":"article","venue":"Clinical Lymphoma Myeloma & Leukemia","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"McGill University; Jewish General Hospital; Roche (Canada)","funders":"Genentech; F. Hoffmann-La Roche; Roche; Roche Canada","keywords":"Medicine; Internal medicine; Cytokine release syndrome; Follicular lymphoma; Neutropenia; Lymphoma; Adverse effect; Febrile neutropenia; Gastroenterology; Tumor lysis syndrome; Refractory (planetary science); Rituximab; Cyclophosphamide; Oncology; Surgery; Cancer; Chemotherapy; Immunotherapy","authors":[{"name":"Matthew J. Matasar","is_ca":false},{"name":"Nancy L. Bartlett","is_ca":false},{"name":"Mazyar Shadman","is_ca":false},{"name":"Lihua E. Budde","is_ca":false},{"name":"Ian W. Flinn","is_ca":false},{"name":"Gareth P. Gregory","is_ca":false},{"name":"Won Seog Kim","is_ca":false},{"name":"Georg Heß","is_ca":false},{"name":"Dima El‐Sharkawi","is_ca":false},{"name":"Catherine Diefenbach","is_ca":false},{"name":"Huang Huang","is_ca":true},{"name":"Iris To","is_ca":false},{"name":"Joana Parreira","is_ca":false},{"name":"Mei Wu","is_ca":false},{"name":"Antonia Kwan","is_ca":false},{"name":"Sarit Assouline","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03510957312794868,"gpt":0.3631146871045697,"spread":0.328005113976621,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.002811359,0.000838618,0.002118572,0.0004963415,0.0003397979,0.00009451952,0.0009986726,0.0009748288,0.002096807],"category_scores_gemma":[0.000853455,0.0007138659,0.0008403664,0.001819541,0.001062709,0.0003523956,0.001010901,0.0009432687,0.001290082],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002541401,"about_ca_system_score_gemma":0.002122701,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002914053,"about_ca_topic_score_gemma":0.00003764196,"domain_scores_codex":[0.9893112,0.0008861443,0.003711313,0.002390237,0.002097063,0.001604059],"domain_scores_gemma":[0.9934031,0.002179987,0.0006885421,0.002294325,0.0002948527,0.001139182],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.2504818,0.01145148,0.05636534,0.00007815563,0.0003407872,0.001621627,0.0005220108,0.000005027529,0.0001541929,0.00001377813,0.005902842,0.6730629],"study_design_scores_gemma":[0.3404185,0.01581188,0.6163347,0.0002780947,0.0001396905,0.000006034832,0.0002901874,0.001205095,0.0001662298,0.00003600526,0.02472477,0.0005888374],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9844885,0.00008218259,0.00003901993,0.0001688257,0.00183294,0.004566619,0.0001525104,0.0003925183,0.00827685],"genre_scores_gemma":[0.9824604,0.0004567742,0.001212586,0.0006680589,0.001417899,0.0006541195,0.001049228,0.0002334839,0.0118474],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.6724741,"threshold_uncertainty_score":0.9995313,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2254870088","doi":"10.1016/j.clml.2016.01.001","title":"Differences in Quality of Life Between Bendamustine-Rituximab and R-CHOP/R-CVP in Patients With Previously Untreated Advanced Indolent Non-Hodgkin Lymphoma or Mantle Cell Lymphoma","year":2016,"lang":"en","type":"article","venue":"Clinical Lymphoma Myeloma & Leukemia","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Dalhousie University; University of Ottawa","funders":"","keywords":"Medicine; Rituximab; Mantle cell lymphoma; Bendamustine; Vincristine; Internal medicine; Prednisone; CHOP; Quality of life (healthcare); Nausea; Cyclophosphamide; Oncology; Lymphoma; Surgery; Chemotherapy","authors":[{"name":"John M. Burke","is_ca":false},{"name":"Richard H. C. Van Der Jagt","is_ca":true},{"name":"Brad S. Kahl","is_ca":false},{"name":"Peter Wood","is_ca":false},{"name":"Tim E. Hawkins","is_ca":false},{"name":"David MacDonald","is_ca":true},{"name":"Mark Hertzberg","is_ca":false},{"name":"David Simpson","is_ca":false},{"name":"Michael Craig","is_ca":false},{"name":"Kathryn S. Kolibaba","is_ca":false},{"name":"Samar Issa","is_ca":false},{"name":"Mihaela Munteanu","is_ca":false},{"name":"Timothy W. Victor","is_ca":false},{"name":"Ian W. Flinn","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03187746019586746,"gpt":0.3067462599513314,"spread":0.274868799755464,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009304059,0.0008776346,0.003027214,0.0004195798,0.00009803984,0.00004345016,0.0004188628,0.0006329865,0.00009485558],"category_scores_gemma":[0.001132779,0.0005182326,0.0003172301,0.0007803576,0.0006843284,0.0003207506,0.0003140252,0.0001314097,0.00006066167],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001875194,"about_ca_system_score_gemma":0.002086119,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001161519,"about_ca_topic_score_gemma":0.0005340424,"domain_scores_codex":[0.992795,0.0005407135,0.003116996,0.001541153,0.0009223843,0.001083785],"domain_scores_gemma":[0.9938653,0.002794481,0.001085253,0.001099768,0.0003000396,0.0008551568],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.006827441,0.00370928,0.6045561,0.0002159556,0.0001549033,0.0001070102,0.0001486363,3.389315e-7,0.000036749,0.00001843991,0.00005137392,0.3841737],"study_design_scores_gemma":[0.133204,0.003827262,0.8590066,0.001817249,0.0002191903,0.000008180172,0.0001106045,0.0000275302,0.0009965509,0.00003407926,0.0001444662,0.0006043165],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9964727,0.000466973,0.00001877784,0.0003019563,0.0001640864,0.001856724,0.0001950486,0.00008887103,0.0004348462],"genre_scores_gemma":[0.9973872,0.0007403308,0.0007733208,0.0003182046,0.0001410106,0.0002185003,0.00009926503,0.0000970298,0.0002251964],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3835694,"threshold_uncertainty_score":0.999727,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3029322331","doi":"10.1016/j.clml.2020.05.018","title":"Interferon Therapy in Myelofibrosis: Systematic Review and Meta-analysis","year":2020,"lang":"en","type":"review","venue":"Clinical Lymphoma Myeloma & Leukemia","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"National Center for Advancing Translational Sciences; National Cancer Institute; MedImmune; Takeda Canada; Sunesis; Daiichi-Sankyo; CTI Biopharma; National Institutes of Health; Arog Pharmaceuticals; Genentech; Acceleron; Astex Pharmaceuticals; Boehringer Ingelheim; AbbVie; Otsuka America; Memorial Sloan-Kettering Cancer Center; LAM Therapeutics; Novartis; Celgene; Jazz Pharmaceuticals; Takeda Pharmaceuticals U.S.A.; Pfizer; Astellas Pharma US; Astellas Pharma; Constellation Energy Group","keywords":"Medicine; Myelofibrosis; Meta-analysis; Oncology; Internal medicine; Intensive care medicine; Bone marrow","authors":[{"name":"Jan Philipp Bewersdorf","is_ca":false},{"name":"Smith Giri","is_ca":false},{"name":"Rong Wang","is_ca":false},{"name":"Nikolai A. Podoltsev","is_ca":false},{"name":"Christina Williamson","is_ca":false},{"name":"Raajit K. Rampal","is_ca":false},{"name":"Martin S. Tallman","is_ca":false},{"name":"Amer M. Zeidan","is_ca":false},{"name":"Maximilian Stahl","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1528373252975107,"gpt":0.4174541436846737,"spread":0.2646168183871629,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.00182206,0.001593774,0.03261614,0.0005245641,0.00008991427,0.0001171192,0.0005172396,0.0009367599,0.0005832099],"category_scores_gemma":[0.00129709,0.0009381074,0.009456608,0.001973978,0.0002557343,0.0001159252,0.000287047,0.0007583075,0.0004651439],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001204882,"about_ca_system_score_gemma":0.00141264,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00004690164,"about_ca_topic_score_gemma":0.00003056149,"domain_scores_codex":[0.9886173,0.002322738,0.005708905,0.002056446,0.0006636289,0.0006310015],"domain_scores_gemma":[0.9926642,0.00280677,0.001819266,0.001729778,0.0001981947,0.0007817809],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.00005464172,0.0003008485,0.00006909079,0.457806,0.2204263,0.0004480503,0.00002704695,5.168813e-8,1.624086e-8,0.00006923117,0.0005215024,0.3202772],"study_design_scores_gemma":[0.001153695,0.001113442,0.001097196,0.07867712,0.7778999,0.0002036258,0.000008437184,0.000008431479,5.459157e-7,0.00001412819,0.1391788,0.0006447324],"study_design_candidate":"meta_analysis","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00003387777,0.9885717,0.00000638578,0.0009810562,0.00008735663,0.009713247,0.0001458818,0.0001094857,0.0003509865],"genre_scores_gemma":[0.0002166425,0.9860157,0.0002998216,0.005106265,0.0001463531,0.007161029,0.0003372813,0.0001550489,0.0005617982],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.5574735,"threshold_uncertainty_score":0.999681,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2346818737","doi":"10.1016/j.clml.2016.03.005","title":"Bortezomib-Containing Regimens for the Treatment of Newly Diagnosed and Relapsed Amyloid Light Chain Amyloidosis: A Single-Center Experience","year":2016,"lang":"en","type":"article","venue":"Clinical Lymphoma Myeloma & Leukemia","topic":"Amyloidosis: Diagnosis, Treatment, Outcomes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":19,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Alberta Cancer Foundation","funders":"","keywords":"Bortezomib; Amyloidosis; AL amyloidosis; Immunoglobulin light chain; Medicine; Amyloid (mycology); Oncology; Single Center; Center (category theory); Internal medicine; Multiple myeloma; Pathology; Immunology; Chemistry","authors":[{"name":"Víctor H. Jiménez‐Zepeda","is_ca":true},{"name":"Peter Duggan","is_ca":false},{"name":"Paola Neri","is_ca":false},{"name":"Nizar J. Bahlis","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02946033452852724,"gpt":0.302709273698907,"spread":0.2732489391703797,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003775332,0.0005468362,0.0007917437,0.00006719175,0.0002428415,0.00005024816,0.0004514953,0.00045201,0.00002105016],"category_scores_gemma":[0.0009087747,0.0003238487,0.0006242367,0.0001307317,0.000629954,0.00002288905,0.0001623715,0.00005339409,0.00001354083],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004164878,"about_ca_system_score_gemma":0.0002960504,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0000739703,"about_ca_topic_score_gemma":0.0001108324,"domain_scores_codex":[0.9966635,0.0001943871,0.001135239,0.001096413,0.0002367695,0.0006736639],"domain_scores_gemma":[0.9961475,0.001661243,0.000580126,0.001152431,0.0001551855,0.0003035409],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.002290455,0.001579093,0.2707977,0.00002642486,0.0009570075,0.00003604375,0.0008592905,0.00000294523,0.0841382,0.0001763344,0.002883836,0.6362527],"study_design_scores_gemma":[0.03061424,0.009654138,0.5863131,0.0002787765,0.0004601379,0.00006411802,0.000832737,0.00004838404,0.2067401,0.00009631547,0.1639798,0.0009181848],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.992048,0.00324697,0.000571691,0.002095163,0.000482229,0.001248698,0.0001193451,0.00005178753,0.0001360801],"genre_scores_gemma":[0.9891942,0.006263969,0.0008700488,0.0009003931,0.0005300561,0.001236245,0.00004529921,0.00008818831,0.0008716679],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.6353346,"threshold_uncertainty_score":0.9999214,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3090860704","doi":"10.1016/j.clml.2020.09.010","title":"Burden of Treatment Among Older Adults With Newly Diagnosed Multiple Myeloma","year":2020,"lang":"en","type":"article","venue":"Clinical Lymphoma Myeloma & Leukemia","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McMaster University; Juravinski Cancer Centre","funders":"National Cancer Institute; National Center for Advancing Translational Sciences; Agency for Healthcare Research and Quality; National Institutes of Health","keywords":"Medicine; Multiple myeloma; Interquartile range; Disease burden; Internal medicine; Comorbidity; Epidemiology; Odds ratio; Malignancy; Logistic regression; Disease; Emergency medicine; Intensive care medicine","authors":[{"name":"Hira Mian","is_ca":true},{"name":"Mark A. Fiala","is_ca":false},{"name":"Tanya M. Wildes","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03434374143750191,"gpt":0.3153407440774412,"spread":0.2809970026399393,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000255745,0.0007173342,0.001720295,0.0001525458,0.0001579925,0.00004760832,0.0004115615,0.0004618008,0.0003907196],"category_scores_gemma":[0.00150367,0.0005052478,0.0007193284,0.0006340551,0.0007830652,0.0002154413,0.0001857613,0.000314785,0.0004008488],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001056817,"about_ca_system_score_gemma":0.001821551,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001857064,"about_ca_topic_score_gemma":0.0001749798,"domain_scores_codex":[0.994997,0.0002812215,0.001506292,0.001332293,0.0008806986,0.001002531],"domain_scores_gemma":[0.994563,0.001510606,0.0004840399,0.001086127,0.0003966506,0.001959522],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.01044407,0.0007826307,0.4547998,0.000220958,0.0009600511,0.002521058,0.001170035,0.00004377313,0.0002217232,0.00001634895,0.0008653544,0.5279542],"study_design_scores_gemma":[0.05382907,0.008332623,0.9197009,0.0006588115,0.0003884093,0.00007606154,0.0006070384,0.01007234,0.003160029,0.000007224674,0.002717312,0.0004501402],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9938287,0.0004091176,0.0001178254,0.001059338,0.0001314106,0.002318838,0.0001093047,0.0002641969,0.001761308],"genre_scores_gemma":[0.9937316,0.0003867104,0.003161415,0.0005392805,0.0008759547,0.0002748802,0.0002872557,0.0001386696,0.0006042227],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.5275041,"threshold_uncertainty_score":0.9997399,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null}]}